document type sequence filename description exclusive license agreement text html head title title head body style font time roman time serif style margin style font time roman time serif margin nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width font size font style font size confidential treatment requested pursuant rule font style width font size text align right font style font size exhibit font table style font time roman time serif margin nbsp style font time roman time serif margin certain confidential portion this exhibit indicated have been omitted pursuant rule security exchange omitted material have been filed separately with security exchange commission style font time roman time serif margin nbsp style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center exclusive license agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent this font style font variant small exclusive license agreement font ldquo agreement rdquo entered into effective march ldquo effective date rdquo between navidea biopharmaceuticals company organized existing under delaware with principal place business located blazer parkway suite dublin ldquo company rdquo spepharm company organized existing under switzerland with office located kapellplatz luzern switzerland ldquo spepharm rdquo solely purpose section article norgine company organized existing under netherlands with office located hogehilweg amsterdam zuid oost netherlands ldquo norgine rdquo company spepharm each referred herein name ldquo party rdquo collectively ldquo party rdquo style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center recital style font time roman time serif margin text align justify text indent font style font variant small nbsp font style font time roman time serif margin text align justify text indent font style font variant small whereas font company engaged development manufacturing commercialization product defined below style font time roman time serif margin text align justify text indent font style font variant small nbsp font style font time roman time serif margin text align justify text indent font style font variant small whereas font spepharm affiliate defined below have capability resource develop market sell commercialize product licensed territory defined below fulfill need requirement customer purchase product licensed territory style font time roman time serif margin text align justify text indent font style font variant small nbsp font style font time roman time serif margin text align justify text indent font style font variant small whereas font company desire grant exclusive license appoint spepharm with right spepharm desire accept from company such exclusive license right develop market promote sell offer sale distribute otherwise commercialize product licensed territory term subject condition stated herein style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center agreement style font time roman time serif margin text align justify text indent font style font variant small nbsp font style font time roman time serif margin text align justify text indent font style font variant small therefore font consideration foregoing other good valuable consideration receipt sufficiency which hereby acknowledged party agree follows style font time roman time serif margin text align center text indent nbsp style font time roman time serif margin text align center text indent article ndash definition style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent when used this agreement capitalized term will have meaning defined below throughout this agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo accounting standard rdquo shall mean generally accepted accounting principle gaap international financial reporting standard ifrs designated used applicable person style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin indicates deleted language style font time roman time serif margin nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo additional indication rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo additional product rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo additional product license rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo affiliate rdquo shall mean person whether jure facto that directly indirectly through more intermediary control controlled under common control with party regardless whether such affiliate becomes affiliate after effective date person shall deemed ldquo control rdquo another person owns directly indirectly beneficially legally least fifty percent outstanding voting security capital stock such lesser percentage which maximum allowed owned person particular jurisdiction such other person other comparable ownership interest with respect person other than corporation power whether pursuant contract ownership security otherwise direct management policy person style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo notice period rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo agreement rdquo shall have meaning forth introductory paragraph hereof style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo applicable rdquo shall mean rule regulation directive guidance governmental authority pertaining development manufacture extrusion packaging labeling storage marketing sale distribution intended product amended from time time style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo business combination rdquo mean with respect party following event third party group third party acting concert ldquo group rdquo within meaning section security exchange acquires including tender exchange offer issuance such party directly indirectly beneficial ownership right acquire beneficial ownership share such party representing fifty percent more voting share where voting refers being entitled vote election director then outstanding such party excluding such purpose transaction series transaction with financial investor defined below made bona fide equity financing purpose which cash received party indebtedness such party cancelled converted combination thereof such party consolidates with merges into another corporation entity which third party corporation entity which third party consolidates with merges into such party either event pursuant transaction which more than fifty percent voting share acquiring resulting entity outstanding immediately after such consolidation merger held holder outstanding voting share such party immediately preceding such consolidation merger such party sell transfer lease otherwise disposes substantially asset third party style font time roman time serif margin text align justify text indent nbsp field page sequence option newsection value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text indent style font time roman time serif margin text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo business program rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo calendar year rdquo shall mean twelve month period commencing january ending december style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo commercialization rdquo with correlative meaning ldquo commercialize rdquo ldquo commercializing rdquo mean activity undertaken relating specifically launch launch promotion market access detailing pricing reimbursement marketing sale distribution product licensed territory including strategic marketing sale force detailing advertising medical education liaison market access study generating pricing reimbursement data licensed territory product distribution importation exportation invoicing sale activity style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo commercialization plan rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo commercially reasonable effort rdquo shall mean those effort resource that similarly situated pharmaceutical company would reasonably devote exercise commercially reasonable practice relating product owned which right type licensed hereunder which similar market potential similar stage development product life taking into account competitiveness global local marketplace pricing launching strategy respective product proprietary position product profitability considering payment either party pursuant this agreement relative potential safety efficacy product other relevant factor including technical legal scientific regulatory medical factor ldquo commercially reasonable rdquo used herein shall interpreted corresponding manner style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo company rdquo shall have meaning forth introductory paragraph hereof style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo company development plan rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo company indemnitees rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text indent style font time roman time serif margin text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo company know rdquo shall mean information controlled subject section company affiliate effective date thereafter during term defined below each case extent related necessary useful development manufacture sale commercialization product clarity ldquo affiliate rdquo this definition shall exclude third party that becomes affiliate after effective date business combination company provided that information controlled company affiliate immediately prior business combination company shall continue controlled company affiliate after such business combination information made developed conceived reduced practice otherwise owned such third party affiliate including company whether solely jointly connection with research development sale offer sale manufacture other commercialization product shall deemed controlled company affiliate purpose this agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo company mark rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo company patent rdquo shall mean patent right licensed territory controlled company affiliate effective date thereafter during term that would license granted herein infringed development manufacture sale offer sale keeping whether sale otherwise importation commercialization product company patent existing effective date without limitation forth exhibit style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo company territory rdquo mean worldwide except licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo competitive infringement rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo confidential information rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo control rdquo ldquo controlled rdquo shall mean with respect information patent right other intellectual property right proprietary trade secret information legal authority right whether ownership license otherwise party grant license sublicense under such information patent right intellectual property right another person otherwise disclose such proprietary trade secret information another person without breaching term agreement with third party misappropriating proprietary trade secret information third party style font time roman time serif margin text align left text indent nbsp style font time roman time serif margin text align left text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo rdquo ldquo rdquo shall mean calendar unless otherwise specified style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo developing party rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo disclosing party rdquo shall have meaning forth section style font time roman time serif margin text align left text indent nbsp style font time roman time serif margin text align left text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo divest rdquo ldquo divestiture rdquo mean divestiture business program through outright sale assignment substantially right such business program third party exclusive even with respect party affiliate license right obligation including research development manufacture commercialization right obligation with respect such business program with further material role influence authority party affiliate with respect such business program style font time roman time serif margin text align left text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text indent style font time roman time serif margin text indent nbsp style font time roman time serif margin text align left text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo dollar rdquo ldquo rdquo shall mean legal tender united state style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo effective date rdquo shall have meaning forth introductory paragraph hereof style font time roman time serif margin text align left text indent nbsp style font time roman time serif margin text align left text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo euro rdquo ldquo euro rdquo shall mean currency participating member state european union style font time roman time serif margin text align left text indent nbsp style font time roman time serif margin text align left text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo excluded information rdquo shall have meaning forth section style font time roman time serif margin text align left text indent nbsp style font time roman time serif margin text align left text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo excluded regulatory material rdquo shall have meaning forth section style font time roman time serif margin text align left text indent nbsp style font time roman time serif margin text align left text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo expanded territory rdquo shall mean those country territory listed exhibit attached hereto style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo field rdquo shall mean style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo financial investor rdquo mean investor series affiliated investor whose primary business investment capital financial gain including venture capital fund private equity fund pension fund called ldquo angel investor rdquo case excluding called ldquo strategic investor rdquo such biotechnology company specialty pharmaceutical company pharmaceutical company generic pharmaceutical company medical device company their affiliate such strategic venture style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo first commercial sale rdquo mean particular country first commercial sale which revenue been recognized spepharm affiliate sublicensees third party such country licensed territory after obtaining product approval including pricing reimbursement approval applicable required order sell such product such country style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo fiscal year rdquo shall mean spepharm rsquo fiscal year beginning january each year style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo force majeure event rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo general rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text indent style font time roman time serif margin text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo generic product rdquo mean pharmaceutical product same dosage form sold third party authorized behalf spepharm affiliate sublicensees that approved interchangeable with product through abbreviated route approval regulatory authority which approval reference product approved same indication through regulatory pathway referencing clinical data first submitted company affiliate licensee spepharm affiliate sublicensees obtaining product approval product style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo improvement rdquo mean enhancement modification product rsquo dose dosage form strength presentation preparation packaging including volume formulation style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo indemnification claim notice rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo indemnified party rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo indemnifying party rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo information rdquo shall mean data result technology information type whatsoever tangible intangible form including trade secret scientific technical regulatory information process method technique material technology result analysis laboratory clinical clinical data other know whether patentable including pharmacology toxicology drug stability manufacturing formulation data methodology technique clinical clinical safety efficacy study marketing study absorption distribution metabolism excretion study excluding patent right style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo initial indication rdquo mean imaging intraoperative detection sentinel lymph node draining primary tumour adult patient with breast cancer melanoma localised squamous cell carcinoma oral cavity style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo initial territory rdquo shall mean country territory included within company rsquo european medicine agency marketing authorization effective date product which austria belgium bulgaria croatia republic cyprus czech republic denmark estonia finland france germany greece hungary iceland ireland italy latvia liechtenstein lithuania luxembourg malta netherlands norway poland portugal romania slovakia slovenia spain sweden united kingdom style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo invention rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo joint rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo jointly funded data rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo licensed territory rdquo shall mean initial territory expanded territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo litigation condition rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo loss rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo major market country rdquo mean style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo marketing material rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo negotiation period rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo sale rdquo shall mean country country product product basis with respect period each country licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo developing party rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo norgine rdquo shall have meaning forth introductory paragraph hereof style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo party rdquo ldquo party rdquo shall have meaning forth introductory paragraph hereof style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo patent challenge rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo patent right rdquo shall mean patent patent application which purpose this agreement shall deemed include certificate invention application certificate invention including divisionals continuation substitution continuation part examination reissue addition renewal revalidations extension registration pediatric exclusivity period supplemental protection certificate like such patent patent application utility model short term patent foreign equivalent foregoing style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo person rdquo shall mean natural person corporation partnership limited liability company business association joint venture other entity style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo agreement rdquo shall have meaning specified section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo trial rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text indent style font time roman time serif margin text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo product rdquo shall mean with without labeling clarity reference this agreement product shall always mean unless otherwise expressly stated refer only style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo product rdquo shall mean product approved radiolabeling with technetium containing lymphoseek alternative replacement name with chemical name tilmanocept current micro multi dose volume packaging configuration effective date other multi dose volume packaging configuration improvement thereto thereof style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo product approval rdquo shall mean authorization permit approval that issued regulatory authority necessary distribution promotion sale product particular country jurisdiction including pricing reimbursement approval style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo product rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo product mark rdquo shall mean product related trademark used company company territory product including those listed part exhibit updated from time time company style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo field rdquo shall mean drug diagnosis rheumatologic condition human including rheumatoid arthritis psoriatic arthritis osteo arthritis ankylosing spondylitis further including manifestation such disease joint cartilage synovium entheses style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo field license agreement rdquo shall mean that certain license agreement between company tcra imaging ldquo tcra rdquo wholly owned subsidiary ldquo rdquo dated june style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo field licensee rdquo shall mean tcra affiliate licensee sublicense assignee successor whether operation merger otherwise thereof style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo field right rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo receiving party rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text indent style font time roman time serif margin text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo regulatory authority rdquo shall mean applicable government regulatory authority involved granting approval promotion sale distribution import export handling reimbursement pricing product style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo regulatory data rdquo shall mean regulatory information data result relating product which necessary product approval including vitro product testing data study data data query data table report case report form generated during clinical clinical study registry study product style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo regulatory material rdquo shall mean regulatory application submission notification communication correspondence registration product approval other filing made received from otherwise conducted with regulatory authority distribution promotion importation exportation pricing reimbursement marketing sale product particular country jurisdiction style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo relevant executive member rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo repurchase price rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo right reference rdquo meaning assigned such term sect analogous applicable recognized outside united state style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo rofn rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo rofn notice rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo royalty term rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo segregate rdquo mean with respect business program commercially reasonable effort segregate development manufacture commercialization activity relating such business program from development manufacture commercialization activity with respect product licensed under this agreement including ensuring that personnel involved performing development manufacture commercialization such business program have access material public plan information relating development manufacture commercialization product personnel involved materially performing development manufacture commercialization product field under this agreement have access public plan information relating development manufacture commercialization such business program provided that either case management personnel review evaluate plan information regarding development manufacture commercialization such business program solely connection with portfolio decision making among product opportunity product general joint practiced used development manufacture commercialization business program style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo spepharm rdquo shall have meaning forth introductory paragraph hereof style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo spepharm development plan rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo spepharm excluded right rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo spepharm indemnitees rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo spepharm rdquo mean patent right information controlled spepharm affiliate sublicensees extent spepharm receives right from sublicensees date termination this agreement that necessary uniquely specific development marketing promotion importation sale offer sale distribution manufacture having manufactured otherwise commercializing product excludes general joint style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo spepharm witholding action rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo sublicensee rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo successor entity rdquo shall have meaning forth section viii style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo supply agreement rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo term rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo territory rdquo shall mean with respect company company territory with respect spepharm licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo third party rdquo shall mean entity other than company spepharm norgine their respective affiliate style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo third party claim rdquo shall have meaning forth section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo upstream agreement rdquo shall mean that certain license agreement between company regent university california effective july that certain amended restated license agreement between company regent university california effective july style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text indent style font time roman time serif margin text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp ldquo rdquo shall mean united state america including possession territory thereof style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp ldquo export control rdquo shall mean applicable regulation relating export export commodity technology service including limited export administration sect sect international emergency economic power sect sect trading with enemy sect sect export control sect sect international boycott provision section internal revenue code style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp ldquo valid claim rdquo shall mean with respect country claim pending patent application which been pending five year from date filing earliest priority patent application which such pending patent application entitled claim benefit issued unexpired patent right including supplementary protection certificate patent term extension like extent such claim been rejected revoked held invalid unenforceable patent office court other governmental agency competent jurisdiction final appealable judgment judgment from which appeal taken within allowable time period abandoned surrendered disclaimed denied admitted invalid unenforceable through reissue examination disclaimer otherwise style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp ldquo weighted average price rdquo shall mean total sale divided number unit sold each case across referenced major market country over three month period prior date calculation style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp interpretation this agreement unless otherwise specified style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp ldquo includes rdquo ldquo including rdquo shall mean respectively includes including without limitation style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp unless context otherwise requires word ldquo rdquo shall deemed include word ldquo rdquo shall mean ldquo rdquo style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp word denoting singular shall include plural vice versa word denoting gender shall include gender style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp word such ldquo herein rdquo ldquo hereof rdquo ldquo hereunder rdquo refer this agreement whole merely particular provision which such word appear style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp exhibit other attachment form part operative provision this agreement reference this agreement shall include reference exhibit attachment style font time roman time serif margin text align center text indent nbsp style font time roman time serif margin margin bottom text align center article ndash grant right license exclusivity style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp license spepharm retained right style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp license grant subject term condition this agreement including section company hereby grant spepharm affiliate exclusive even company affiliate right license with right grant sublicenses accordance with section under company patent company know joint joint study data develop market promote import sell offer sale keep whether sale otherwise distribute otherwise commercialize product each case field licensed territory exclusive with company affiliate right license licensed territory exclusive right license outside licensed territory with right grant sublicenses accordance with section under company patent company know joint joint study data manufacture have manufactured product field licensed territory license granted spepharm rsquo affiliate under this section shall terminate when such entity longer affiliate spepharm style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp company retained right notwithstanding right granted spepharm affiliate section company retains right interest other than expressly granted under this agreement including without limitation right manufacture have manufactured product worldwide conduct activity specified section hereunder subject section conduct have conducted clinical trial other study licensed territory generation data support regulatory submission regulatory authority company territory subject section conduct activity licensed territory with respect research development manufacture product commercialization company territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp sublicense right style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp negative covenant spepharm covenant that will will grant license otherwise authorize affiliate sublicensees practice company patent company know outside scope license granted under section above style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp implied right except license right expressly granted under this agreement right title interest with respect product other intellectual property interest implication otherwise under trademark information patent right owned controlled company granted company spepharm hereunder style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp upstream agreement company patent sublicensed under section licensed company pursuant upstream agreement spepharm covenant comply cause sublicensees comply with material term upstream agreement applicable sublicensees material respect current copy which have been provided spepharm effective date company acknowledges that spepharm rsquo sublicensees rsquo compliance with diligence obligation expressly forth this agreement shall satisfy requirement preceding sentence with respect diligence obligation applicable sublicensees under upstream agreement spepharm acknowledges agrees that sublicense right with respect such company patent under this agreement time subject limited applicable term upstream agreement including scope license granted company event inconsistency between this agreement applicable upstream agreement upstream agreement shall control without limitation preceding sentence company shall amend agree amend term condition upstream agreement manner that would adversely affect right granted spepharm licensed territory under this agreement without prior written consent spepharm company further agrees that shall terminate either upstream agreement without prior written consent spepharm company shall comply with material term upstream agreement material respect shall timely make payment required made thereunder provided that company shall breach foregoing obligation extent that company rsquo failure comply result from spepharm rsquo compliance with term upstream agreement required under this section avoidance doubt company solely responsible payment obligation under upstream agreement company shall notify spepharm when received notice from third party that party upstream agreement stating that such third party intends terminate terminating upstream agreement company shall further notify spepharm issue which company aware that given could reasonably expected give rise material dispute under either upstream agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp exclusivity style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp during term spepharm shall shall cause affiliate directly indirectly itself with third party develop promote market import sell offer sale distribute otherwise commercialize anywhere licensed territory product except product under this agreement style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp during term company shall shall cause affiliate directly indirectly itself with third party develop promote market import sell offer sale distribute otherwise commercialize anywhere licensed territory product provided that foregoing restriction shall apply development product under this agreement extent permitted hereunder product that offered licensed spepharm under section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp notwithstanding this section business combination occurs with respect spepharm affiliate third party such third party rsquo affiliate successor assigns such third party such third party rsquo affiliate immediately prior such business combination program that existed prior planned prior demonstrably implemented shortly after would developed independently intellectual property licensed hereunder after business combination that would otherwise violate this section ldquo business program rdquo then such third party such third party rsquo affiliate successor assigns such third party such third party rsquo affiliate including spepharm affiliate business combination applicable will permitted continue such business program after such business combination such continuation will constitute violation this section long such third party acquirer third party acquirer rsquo affiliate segregate business program style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp notwithstanding this section business combination occurs with respect company third party such third party rsquo affiliate successor assigns such third party such third party rsquo affiliate immediately prior such business combination business program that existed prior planned prior demonstrably implemented shortly after business combination would developed independently intellectual property licensed hereunder after then such third party such third party rsquo affiliate successor assigns such third party such third party rsquo affiliate including company affiliate business combination applicable will permitted continue such business program after such business combination such continuation will constitute violation this section long such third party acquirer third party acquirer rsquo affiliate segregate business program provided that spepharm rsquo election shall dissolved spepharm shall have final decision making authority with respect matter which review right responsibility provided that last paragraph section shall continue apply style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp spepharm affiliate acquires third party including merger consolidation that such third party becomes affiliate over which spepharm such affiliate control defined section spepharm affiliate acquires substantially asset third party including subsidiary division thereof third party such third party rsquo affiliate successor assigns such third party such third party rsquo affiliate immediately prior such business combination acquired asset contain applicable business program then spepharm shall promptly notify company such business program within five after such business combination spepharm such third party such third party rsquo affiliate successor assigns such third party such third party rsquo affiliate applicable will style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp company affiliate acquires third party including merger consolidation that such third party becomes affiliate over which company such affiliate control defined section company affiliate acquires substantially asset third party including subsidiary division thereof third party such third party rsquo affiliate successor assigns such third party such third party rsquo affiliate immediately prior such business combination acquired asset contain applicable business program then company shall promptly notify spepharm such business program within five after such business combination company such third party such third party rsquo affiliate successor assigns such third party such third party rsquo affiliate will style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp each party acknowledges agrees that restriction forth this section considered party reasonable purpose protecting goodwill value other party rsquo business each party acknowledges that other party irreparably harmed that monetary damage provide adequate remedy other party event covenant contained this section were complied with accordance with their term accordingly each party agrees that breach provision this section shall entitle other party without limit other right have injunctive other equitable relief secure enforcement these provision addition other remedy including damage which available other party style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp desire intent party that provision this section enforced fullest extent permissible under public policy each jurisdiction which enforcement sought provision this section relating time period scope activity geographic area restriction declared court competent jurisdiction exceed maximum permissible time period scope activity geographic area case time period scope activity geographic area shall reduced maximum which such court deems enforceable provision this section other than those described preceding sentence adjudicated invalid unenforceable invalid unenforceable provision shall deemed amended with respect only jurisdiction which such adjudication made such manner render them enforceable effectuate nearly possible original intention agreement party style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp cross territorial restriction style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp unless otherwise expressly authorized company writing spepharm shall actively seek prospective purchaser product company territory engage advertising promotional activity relating product directed primarily prospective purchaser company territory solicit order from prospective purchaser sale company territory spepharm receives order from prospective purchaser company territory spepharm shall promptly refer that order company shall accept such order spepharm shall sell product purchaser spepharm know that such purchaser intends resell otherwise distribute provide such product prospective purchaser company territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp unless otherwise expressly authorized spepharm writing company shall actively seek prospective purchaser product licensed territory engage advertising promotional activity relating product directed primarily prospective purchaser licensed territory solicit order from prospective purchaser sale licensed territory company receives order from prospective purchaser licensed territory company shall promptly refer that order spepharm shall accept such order company shall sell product purchaser company know that such purchaser intends resell otherwise distribute provide such product prospective purchaser licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp rofn additional product company hereby grant spepharm first right negotiate exclusive right market sell distribute commercialize licensed territory imaging agent controlled company affiliate during term ldquo additional product rdquo ldquo rofn rdquo accordance with this section event that company affiliate proposes directly indirectly enter into license other arrangement with third party time during term pursuant which such third party would receive right market sell distribute commercialize additional product ldquo additional product license rdquo then company shall notify spepharm writing ldquo rofn notice rdquo prior engaging such activity clarity company shall notify spepharm upon receipt prior entering into discussion binding commitment with respect unsolicited offer proposal additional product license from third party within thirty receiving rofn notice spepharm notifies company writing that wish exercise rofn party shall negotiate good faith exclusive basis period exceed ninety after company rsquo receipt such written notification party reach agreement term include such additional product under this agreement party shall amend this agreement based upon agreed upon term period company spepharm unable reach agreement such term company shall free enter into additional product license such additional product company shall have further obligation spepharm with respect such additional product clarity agreement with contractor contract research organization contract manufacturer other third party which agreement provides solely performance contract service behalf company shall subject this section this section shall triggered business combination company assignment transfer this agreement right obligation hereunder third party pursuant section event company acquired third party connection with business combination term this section will longer apply style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp additional indication style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp event that either party affiliate interested developing product indication other than initial indication each ldquo additional indication rdquo shall propose such development discussion party other party indicates within sixty business such proposal development other party ldquo notice period rdquo interested jointly developing product additional indication with first party party agree negotiate term such development including development plan that would satisfy requirement such additional indication role responsibility party such development sharing cost expense that would incurred party developing product such additional indication party agree that such negotiation shall occur least sixty after other party referenced above indicated interest additional indication such other period time mutually agreed party ldquo negotiation period rdquo party reach mutual agreement such term party shall document such agreement writing style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp party reach agreement term developing product additional indication within negotiation period party indicated interested failed indicate within notice period interested jointly developing with other party product additional indication then each party shall have right independently develop product such additional indication respective territory provided that notwithstanding anything contrary this agreement including section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp such right independently develop product subject without limitation section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp information including clinical data manufacturing information generated behalf such party ldquo developing party rdquo affiliate licensee sublicensees conduct development commercialization product additional indication ldquo excluded information rdquo shall excluded from license other right granted other party ldquo developing party rdquo under this agreement provided that such excluded information generated conduct development commercialization product additional indication either initial indication different additional indication which party have mutually agreed develop pursuant section above then excluded information shall excluded from license other right granted developing party with respect initial indication such different additional indication style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp developing party affiliate licensee sublicensees shall have right shall refer rely upon otherwise make excluded information regulatory material product additional indication that controlled developing party affiliate licensee sublicensees ldquo excluded regulatory material rdquo other than solely necessary comply with safety reporting obligation regulatory authority with respect initial indication different additional indication which party have mutually agreed develop pursuant section above style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp subject field licensee rsquo right field under field license agreement neither party affiliate licensee sublicensees shall seek obtain product approval product additional indication developing party rsquo territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp avoidance doubt subject clause above field shall continue include additional indication including purpose license granted spepharm affiliate under section licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent developing party desire obtain access excluded information excluded regulatory material developing party agrees negotiate good faith term such access including consideration paid developing party such access style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent purpose this section reference ldquo licensee rdquo when referring company rsquo licensee shall include spepharm affiliate style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp field style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp notwithstanding anything contrary herein style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp field licensee shall have company affiliate other licensee excluding spepharm affiliate shall have field license sublicense other right including right reference rely upon under directly indirectly information confidential information patent right controlled other than where controlled result license granted under section spepharm affiliate licensee sublicensees including general product information generated under this agreement from clinical study funded whole part spepharm affiliate regulatory material owned held possessed spepharm affiliate licensee sublicensees including product approval product licensed territory excluding product approval regulatory data regulatory material assigned licensed company spepharm under this agreement through collectively ldquo spepharm excluded right rdquo product mark style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp neither company affiliate other person acting through them shall directly indirectly grant otherwise convey field licensee license sublicense other right including right reference rely upon under spepharm excluded right product mark disclose otherwise make available spepharm excluded right field licensee style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp neither company affiliate licensee sublicensees other than field licensee pursuant field license agreement shall directly indirectly sell distribute otherwise commercialize product field licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp field licensee directly indirectly sell distributes otherwise commercializes product country initial territory such product shall deemed generic product each every country initial territory section shall apply long such sale distribution commercialization continues style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp field licensee directly indirectly sell distributes otherwise commercializes product country expanded territory such product shall deemed generic product such country expanded territory section shall apply long such sale distribution commercialization continues style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp field licensee directly indirectly sell distributes otherwise commercializes product country licensed territory spepharm rsquo obligation milestone payment under section that come after first date such sale distribution commercialization shall terminate style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp style font time roman time serif margin text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp expanded territory after effective date spepharm shall provide company with development plan each each such plan shall include those activity designed obtain product approval timely manner consistent with exercise commercially reasonable effort will include initiation material development activity consistent with commercially reasonable effort later than from date such plan from time time during term spepharm shall have right make commercially reasonable amendment such development plan spepharm will provide proposed amendment review will reasonably consider comment from with respect such amendment spepharm will update from time time plan develop product expanded territory country aside from licensed territory shall redefined exclude where spepharm provide development plan such country accordance with this section such redefinition licensed territory shall constitute company rsquo sole remedy such provision such development plan style font time roman time serif margin text align center text indent nbsp style font time roman time serif margin margin bottom text align center article ndash governance style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp joint management committee style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp promptly after effective date party will establish joint management committee ldquo rdquo composed least three representative from each party that number necessarily required same each party each party change representative from time time sole discretion effective upon notice other party such change these representative shall have appropriate experience knowledge shall coordinate activity party under this agreement discus measure facilitating product rsquo successful development commercialization licensed territory upon written notice other party either party invite reasonable number member representative including without limitation employee employee professional representative have reasonable purpose attending such meeting portion such meeting bound obligation confidentiality least protective those forth this agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp meeting shall meet least semi annual basis such other time party agree meeting shall held such date location mutually agreed held person teleconference videoconference party agree that cost incurred each party connection with participation meeting under this section shall borne solely such party style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp role subject foregoing shall responsible style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp reviewing discussing strategy obtaining product approval reviewing strategic regulatory material needed including product approval filing product licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp reviewing discussing development manufacturing marketing distribution commercialization product licensed territory including chemistry manufacturing control ldquo rdquo work which required necessary approval commercialization plan style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp reviewing discussing progress clinical trial required fulfill paediatric investigation plan agreed with style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp reviewing discussing clinical trial involving product including market access trial conducted licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp reviewing discussing company development plan spepharm development plan style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp establishing such joint subcommittee committee party agree writing necessary achieve objective intent this agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp performing such other function agreed party writing style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent notwithstanding other provision this section shall have only power assigned expressly this section elsewhere this agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp quorum decision making quorum meeting shall representative from each party meeting member from each respective party shall have aggregate vote irrespective number representative from each party actually attendance meeting decision shall made unless both party have voted favor thereof style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp chair unless otherwise mutually agreed between party chair shall alternate between representative each party each meeting first chair shall representative spepharm style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp decision making unanimously resolve disagreement within thirty after first addressing such matter either party written notice other party have such dispute referred chief operating officer closest equivalent ldquo relevant executive member rdquo each party their designees attempted resolution good faith negotiation within thirty after such notice received relevant executive member unable agree matter resolve issue referred within fifteen after such matter referred them such longer period party agree such dispute shall referred chief executive officer each party their designees attempted resolution good faith negotiation within fifteen after such notice received provided however that each party shall have final decision making authority discretion with respect following matter extent forth this agreement style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp spepharm rsquo decision spepharm shall have authority discretion decide matter related except provided section development product licensed territory regulatory material product approval regulatory matter concerning product licensed territory conduct clinical trial involving product conducted licensed territory including clinical trial which done market access pricing reimbursement purpose product licensed territory commercialization product within licensed territory including commercialization plan excluding training provided pursuant section which shall require mutual agreement party related work which required necessary product approval product licensed territory after first product approval licensed territory related seeking product approval expanded territory maintaining product approval product licensed territory related activity licensed territory that could reasonably deemed have material adverse effect commercialization product field licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp company rsquo decision company shall have authority discretion decide matter relating development manufacture commercialization product company territory conduct work which required necessary first product approval licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent notwithstanding foregoing party having final decision making authority under this section shall have right exercise final decision making authority unilaterally determine that fulfilled obligation under this agreement that other party breached obligation under this agreement determine that milestone event required payment milestone payment occurred make decision that expressly stated require mutual agreement party which clarity encompass matter approved otherwise expand right reduce obligation under this agreement determine issue manner that would conflict with term condition this agreement require company make expenditure conduct activity otherwise specified company development plan require spepharm make expenditure conduct activity otherwise specified spepharm development plan style font time roman time serif margin text align center text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin margin bottom text align center article ndash product development style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp product development subject term this agreement spepharm will responsible development product licensed territory except expressly assigned company style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp development responsibility company company shall responsible sole cost expense except provided section following activity product licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp designing conducting accordance with applicable protocol mutually agreed party clinical clinical trial which required product approval excluding pricing reimbursement approval product initial territory regulatory authority style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp designing conducting accordance with applicable protocol mutually agreed party clinical trial which required fulfill paediatric investigation plan agreed with ldquo trial rdquo provided that company spepharm will share equally pocket cost expense such trial will mutually agreed party writing prior commencement such trial with spepharm rsquo share exceed style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp conducting work which required necessary first product approval licensed territory required necessary connection with supply product spepharm under supply agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent each case subject review discussion style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent development plan detailing foregoing development activity attached hereto exhibit ldquo company development plan rdquo from time time during term company shall have right amend then current company development plan company will provide proposed amendment review will reasonably consider comment from with respect such amendment company shall commercially reasonable effort conduct development activity forth company development plan style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp development responsibility spepharm spepharm shall responsible sole cost expense style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp designing conducting clinical trial required necessary market access pricing reimbursement purpose product licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp providing reasonable requested advice expertise company with respect work conducted company which required necessary first product approval licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp conducting work which required necessary product approval after first product approval licensed territory except provided section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp using commercially reasonable effort conduct other commercially reasonable development activity other than those that company rsquo responsibility pursuant section that required necessary obtain product approval licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent spepharm shall prepare plan setting forth development activity including market access other study that will conducted spepharm initial territory pursuant this section ldquo spepharm development plan rdquo from time time during term spepharm shall have right amend then current spepharm development plan spepharm will provide proposed amendment review will reasonably consider comment from with respect such amendment spepharm shall commercially reasonable effort conduct development activity forth spepharm development plan without limiting generality foregoing party shall review discus through schedule filing regulatory application such product approval such country style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent event that spepharm determines that commercially reasonable file regulatory application product approval product commercialize product particular country licensed territory then spepharm shall promptly discus such matter with style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp clinical trial style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp party shall discus conduct spepharm market access study generating pricing reimbursement data product licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp spepharm intends initiate conduct investigator trial clinical trial necessary desirable seek maintain product approval product licensed territory spepharm shall discus such trial with company reasonably advance their initiation shall good faith consider company rsquo reasonable comment suggestion respect thereof style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp except clinical trial required conducted company pursuant section neither company affiliate licensee sponsor conduct investigator trial clinical trial involving product licensed territory without spepharm rsquo prior written approval such approval unreasonably withheld delayed conditioned style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp company affiliate licensee sponsor conduct investigator trial clinical trial involving product company territory company agrees discus review such trial provided that neither spepharm shall have approval right decision regarding such trial shall company rsquo sole discretion style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp product development activity each party agrees that shall consult with keep other party reasonably apprised developing party rsquo conduct directly indirectly clinical development activity using product respective territory including evaluation product additional field application style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp record information sharing right reference style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp record data information each party shall maintain complete current accurate record work conducted under this agreement data other information resulting from performance such activity sufficient detail good scientific manner appropriate patent regulatory purpose style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp data generated spepharm subject section spepharm shall promptly provide company with copy final report information including clinical data generated behalf spepharm affiliate sublicensees conducting activity under this agreement that controlled spepharm necessary useful development manufacture commercialization product spepharm shall provide such information company soon reasonably practical through information sharing procedure established mutual agreement party notwithstanding other provision this agreement contrary spepharm acknowledges agrees that subject section company disclose such information company rsquo affiliate licensee that company such affiliate licensee free charge such information solely research development manufacture commercialization product company territory research development manufacture commercialization product controlled company other than product licensed territory effective date during term style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp data generated company subject section company shall promptly provide spepharm with copy final report information including clinical data manufacturing information generated behalf company affiliate licensee prior effective date well during term conduct development commercialization product that necessary useful development product approval commercialization product field spepharm licensed territory company shall provide such information spepharm soon reasonably practical through information sharing procedure established mutual agreement party notwithstanding other provision this agreement contrary company acknowledges agrees that subject section spepharm disclose such information with spepharm rsquo affiliate sublicensees that spepharm such affiliate sublicensees free charge such information solely research development manufacture commercialization product licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp right reference subject section company hereby grant spepharm affiliate sublicensees right reference regulatory data regulatory material controlled company affiliate relating product solely extent necessary useful develop manufacture market promote sell distribute commercialize product field licensed territory consistent with term this agreement subject section spepharm hereby grant company affiliate licensee right reference regulatory data regulatory material controlled spepharm affiliate relating product solely extent necessary useful develop manufacture market promote sell distribute commercialize product company territory each party shall provide signed statement regarding foregoing requested other party accordance with sect analogous applicable recognized outside united state style font time roman time serif margin text align center text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin margin bottom text align center article ndash regulatory matter pharmacovigilance style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp transfer existing product approval party shall take shall cause their affiliate take such action reasonably necessary transfer product approval product spepharm affiliate designated spepharm within three month after receipt product approval initial territory including company providing regulatory data spepharm that required submitted regulatory authority connection with spepharm rsquo designated affiliate rsquo application assume such product approval each party shall responsible cost expense incurred connection with such transfer provided that spepharm shall responsible payable regulatory authority connection with such transfer until transfer product approval product spepharm event failure transfer such product approval spepharm designated affiliate company hereby consent grant spepharm affiliate right access reference without further action required part company whose authorization file this consent with regulatory authority hereby granted such product approval style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp preparation filing product approval style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp product approval product been obtained effective date initial territory subject spepharm rsquo input final approval unreasonably withheld company shall expense prepare submission ready regulatory material obtain product approval initial indication initial territory file such regulatory material obtain such product approval initial territory spepharm shall provide company with such advice reasonable consultation assistance requested company connection with foregoing activity style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp spepharm expense shall responsible preparing filing regulatory approval obtain product approval initial indication expanded territory company shall provide spepharm with such advice reasonable consultation assistance requested spepharm connection with foregoing activity including supplying spepharm copy regulatory data regulatory material possessed company affiliate licensee style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp spepharm shall expense commercially reasonable effort obtain consultation with company through product approval initial indication expanded territory those country expanded territory where commercially reasonable subject section style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp maintenance product approval style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp after transfer each product approval licensed territory spepharm designated affiliate obtaining each product approval licensed territory spepharm designated affiliate spepharm such designated affiliate shall commercially reasonable effort maintain consultation with company through such product approval spepharm shall responsible cost expense incurred maintaining such product approval including amount required paid regulatory authority excluding cost expense incurred company affiliate style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp between party product approval product licensed territory shall name spepharm designated affiliate shall indicate spepharm such designated affiliate holder such product approval spepharm shall responsible obtaining maintaining other approval permit license necessary distribution promotion sale product licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp review regulatory material communication with regulatory authority style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp company shall provide spepharm review comment proposed material regulatory material submitted other than routine correspondence regulatory authority licensed territory relating product least business advance submission company shall reasonably consider incorporate such comment from after such time that product approval product held name spepharm company shall submit regulatory material regulatory authority licensed territory relating product spepharm shall furnish company copy material regulatory material other than routine correspondence advance submission where practical that spepharm submits receives from regulatory authority licensed territory relating product consider company rsquo comment good faith well contact report concerning substantive conversation substantive meeting with such regulatory authority each case relating such material regulatory material style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp each party shall provide other party with prior written notice extent party advance knowledge meeting conference discussion including advisory committee meeting with regulatory authority licensed territory relating product within business after party affiliate licensee sublicensee first receives notice scheduling such meeting conference discussion within such shorter period necessary order give other party reasonable opportunity attend such meeting conference discussion extent permitted regulatory authority other party shall have right attend observer participate unless otherwise agreed advance such meeting conference discussion style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp pharmacovigilance responsibility each party regard pharmacovigilance activity including exchange safety information adverse event reporting governmental reporting related follow extent they relate product shall forth separate pharmacovigilance agreement ldquo agreement rdquo between party case affiliate experienced third party acting their behalf such product which shall entered into within ninety after effective date attached hereto exhibit company shall maintain will recognized holder global safety database adverse event report related product received either party their affiliate licensee sublicensees spepharm shall have access thereto shall further specified agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp product recall style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp spepharm sole discretion make decision recalling issuing advisory letter other safety related communication with respect product licensed territory handling such recall spepharm shall bear cost associated with such recall except extent that recall attributable breach this agreement gross negligence willful misconduct company affiliate manufacture product behalf company spepharm shall notify company timely manner connection with such action each party agrees provide reasonable assistance other party event recall issuance advisory letter event that company determined initiate recall product outside licensed territory shall notify spepharm party shall immediately discus cause such action whether initiate recall take other action licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp when spepharm becomes aware information that reasonably suggests that product sold licensed territory have caused contributed death serious injury malfunctioned that product would likely cause contribute death serious injury malfunction were recur spepharm agrees furnish such information company within time period specified agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp when company becomes aware information that reasonably suggests that product sold company territory have caused contributed death serious injury malfunctioned that product would likely cause contribute death serious injury malfunction were recur company agrees furnish such information spepharm within time period specified agreement style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp harmful action either party reasonably belief that other party taking intends take action with respect product that could reasonably expected have material adverse impact upon regulatory status product licensed territory case spepharm company territory case company such party shall have right bring matter attention such other party party shall meet discus impact such action style font time roman time serif margin text align center text indent nbsp style font time roman time serif margin margin bottom text align center article ndash product manufacturing supply style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp product manufacturing supply party shall negotiate good faith enter into definitive supply agreement governing clinical commercial supply product company spepharm spepharm rsquo purchase product from company consistent with term condition term sheet attached hereto exhibit within ninety effective date style font time roman time serif margin text align center text indent nbsp style font time roman time serif margin margin bottom text align center article ndash commercialization style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp product commercialization subject term condition this article spepharm shall responsible party commercialization product field licensed territory without limiting foregoing spepharm shall responsible developing using commercially reasonable effort executing commercial launch launch plan negotiating with applicable regulatory authority regarding price reimbursement using commercially reasonable effort marketing promotion product licensed territory except where company such responsibility under supply agreement manufacture storage shipment transportation distribution invoicing licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp commercialization plan prior anticipated commercial launch spepharm affiliate sublicensees product licensed territory spepharm shall provide company review comment commercialization plan outlining spepharm rsquo good faith plan commercialization product licensed territory ldquo commercialization plan rdquo commercialization plan will reasonable detail include information sale forecast timeline regarding spepharm rsquo commercialization activity style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp commercialization diligence style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp general spepharm shall commercially reasonable effort commercialize initial territory those country which receives product approval which commercially reasonable commercialize product without limiting foregoing spepharm shall commercially reasonable effort develop marketing market access dossier including pricing reimbursement where applicable required spepharm rsquo sole determination diligently promote sale country licensed territory which receives product approval accordance with applicable responsible medical education program with professional clinical liaison within licensed territory style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp major market country style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp during such ninety period spepharm affiliate sublicensees commercially launched major market country such termination shall deemed withdrawn further force effect style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp extent that spepharm affiliate sublicensees commercially launched least major market country accordance with term this section above occurrence adverse event that raise serious safety issue with respect product regulatory hold constraint material restriction imposed raised regulatory authority with respect product manufacture supply delay failure with respect product force majeure event third party alleges writing that manufacture sale product infringes intellectual property there pending infringement action decision court settlement relating infringement action that prevents spepharm from commercially launching product then each through extent that such event occurs within applicable major market country such event would have materially adverse impact commercially reasonable launch such product therein spepharm using commercially reasonable effort remove existence such event then foregoing termination right shall tolled during pendency such event material adverse impact thereof style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent foregoing termination right shall cease apply after been commercially launched major market country after been commercially launched major market country spepharm shall commercially reasonable effort commercialize each such major market country style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp expanded territory spepharm shall commercially reasonable effort commercialize those country expanded territory which receives product approval which commercially reasonable commercialize product style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp review company rsquo request spepharm shall discus meeting following such request basis which spepharm determined commercially reasonable commercialize product country which received product approval style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp price spepharm sell product licensed territory price determined sole discretion style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp company support upon spepharm rsquo request company will commercially reasonable effort support spepharm launch launch activity forth commercialization plan spepharm rsquo cost expense extent provided commercialization plan upon spepharm rsquo request spepharm rsquo cost expense company provide direct support spepharm rsquo customer such case spepharm shall provide company with spepharm rsquo customer rsquo name information that company reasonably request order company provide such support such customer style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp commercialization report spepharm shall update periodically each regularly scheduled meeting regarding spepharm rsquo commercialization activity with respect product licensed territory which update shall summarize spepharm rsquo significant commercialization activity with respect each product country country basis licensed territory pursuant this agreement covering subject matter level detail sufficient enable company determine spepharm rsquo compliance with diligence obligation pursuant section above style font time roman time serif margin text align center text indent nbsp style font time roman time serif margin margin bottom text align center article viii ndash certain obligation party style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp compliance with each party will perform cause performed obligation exercise right hereunder compliance material respect with applicable style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp insurance style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp each party will maintain sole cost expense adequate liability insurance self insurance program including product liability insurance protect against potential liability risk arising activity performed under this agreement including coverage deductible limit self insured retention customary pharmaceutical industry activity conducted such party under this agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp insurance required herein shall maintained during term this agreement ldquo claim made rdquo basis period least five year thereafter each party shall solely responsible payment deductible under such policy maintained style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text align center text indent nbsp style font time roman time serif margin margin bottom text align center article ndash promotional material training style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp promotional material during term spepharm shall expense responsible creation marketing technical information concerning product licensed territory that necessary helpful promotion product licensed territory including limited brochure instructional material advertising literature other product data ldquo marketing material rdquo marketing material created spepharm shall remain property spepharm liability consumer claim arising from inaccurate marketing material translation provided spepharm creation such marketing material shall sole responsibility spepharm except that company shall solely responsible such liability consumer claim extent attributable information including regulatory data regulatory material licensed otherwise provided company spepharm marketing material assist spepharm with creation marketing material company shall provide spepharm with sample branding marketing information brochure english utilized company company territory such information material provided company shall remain property company spepharm shall return same company upon termination this agreement extent they then spepharm rsquo possession control style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp training style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp company shall provide spepharm reasonable level product specific training planned periodic basis spepharm personnel sale force medical liaison marketing personnel mutually agreed upon facility mutually agreed party style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp subject company providing training pursuant section spepharm shall ensure that employee agent engaged promotion sale product under this agreement adequately trained with respect product style font time roman time serif margin text align center text indent nbsp style font time roman time serif margin margin bottom text align center article ndash financial provision style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp upfront license payment partial consideration license right granted spepharm hereunder spepharm shall company refundable creditable payment million dollar within after effective date style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp milestone payment spepharm shall company following refundable creditable except forth section time milestone payment upon first achievement such milestone style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text indent nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width border black solid text align center font style font size milestone font style width border black solid border right black solid border bottom black solid text align center font style font size milestone payment font style vertical align style border right black solid border bottom black solid border left black solid font style font size font style border right black solid border bottom black solid font style font size font style vertical align style border right black solid border bottom black solid border left black solid font style font size font style border right black solid border bottom black solid font style font size font style vertical align style border right black solid border bottom black solid border left black solid font style font size font style border right black solid border bottom black solid font style font size font style vertical align style border right black solid border bottom black solid border left black solid font style font size font style border right black solid border bottom black solid font style font size font style vertical align style border right black solid border bottom black solid border left black solid font style font size font style border right black solid border bottom black solid font style font size font table style font time roman time serif margin text indent nbsp style font time roman time serif margin text align justify text indent spepharm shall notify company writing within thirty following achievement each milestone event above shall make applicable milestone payment within forty five after achievement such milestone event style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp sale milestone payment spepharm shall company following refundable creditable except forth section time milestone payment upon first achievement such milestone style font time roman time serif margin text indent nbsp nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width border black solid text align center font style font size milestone font style width border black solid border right black solid border bottom black solid text align center font style font size milestone payment font style vertical align style border right black solid border bottom black solid border left black solid font style font size font style border right black solid border bottom black solid font style font size font style vertical align style border right black solid border bottom black solid border left black solid font style font size font style border right black solid border bottom black solid font style font size font table style font time roman time serif margin text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp royalty style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp spepharm shall company royalty aggregate sale product licensed territory each calendar year forth below style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse margin left style vertical align style width text align center calendar year sale licensed territory style width text align center royalty rate style vertical align style text align center nbsp style text align center nbsp style vertical align portion aggregate sale licensed territory than equal calendar year style text align center style vertical align nbsp style text align center nbsp style vertical align portion aggregate sale licensed territory greater calendar year style text align center table style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp royalty payable under section shall apply country country basis sale product each country licensed territory commencing date first commercial sale product such country continuing until later such period ldquo royalty term rdquo style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp country country calendar quarter calendar quarter basis generic product sold such country during such calendar quarter then following date first commercial launch such generic product such country royalty payable with respect sale product pursuant section such country thereafter shall reduced royalty otherwise payable pursuant section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp spepharm affiliate sublicensees enters into agreement with third party obtain license under patent right other right that deemed counsel necessary sell otherwise commercialize product licensed territory otherwise practice right under company patent company know granted spepharm section spepharm affiliate sublicensees shall subject final court other binding order ruling settlement agreement requiring payment respect sale other commercialization product country licensed territory spepharm deduct from royalty company payment actually paid such third party such license pursuant such final court other binding order ruling settlement agreement with respect such product such country provided that royalty payable company particular calendar quarter such product such country shall reduced more than reason this section provided further that such payment third party applied reduce royalty result forgoing proviso carried over subsequent calendar quarter applied reduce royalty subject aforementioned limitation such subsequent calendar quarter style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp within forty five after each calendar quarter spepharm shall provide royalty report showing country country basis style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp number unit product sold spepharm affiliate sublicensees during such calendar quarter reporting period style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp gross sale associated with each product sold spepharm affiliate sublicensees during such calendar quarter style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp sale product sold spepharm affiliate sublicensees during such calendar quarter reporting period together with reasonable supporting information underlying calculation sale such period style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp royalty payable euro which shall have accrued hereunder with respect such sale style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp detail correction true from previously reported sale amount style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp withholding required applicable deducted with respect such royalty style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp rate exchange used spepharm under section style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent concurrent with these report spepharm shall remit company payment applicable calendar quarter royalty payment royalty period hereunder spepharm shall report style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp manner payment exchange rate milestone payment made spepharm company under this agreement shall made united state dollar royalty payment made spepharm company under this agreement shall made euro shall paid electronic transfer immediately available fund bank account united state designated writing company sale made currency other than euro currency conversion required rate exchange shall calculated using arithmetic daily average relevant published currency exchange rate from european central bank from source http fxtop across calendar quarter which relevant royalty payment pursuant section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp late payment amount received date billing party rsquo sole discretion subject charge equal lesser annual rate above euribor month annum maximum rate permitted applicable governing this agreement interest shall calculated daily basis year actual number which interest style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp record audit spepharm shall maintain complete accurate book record with respect sale distribution product accordance with accounting standard company shall have right during reasonable business hour with reasonable prior notice more than once calendar year inspect such book record purpose verifying spepharm rsquo payment under this agreement spepharm shall maintain record report required under this agreement relating product period five year longer required applicable company shall make inspection permitted hereunder sole cost expense provided however that event such audit reveals underpayment annual royalty more than spepharm shall bear reasonable pocket cost expense audit result audit performed pursuant this section determined that spepharm under reported information necessary calculate royalty product result company received than should have under this agreement spepharm shall later than thirty after receiving notice such underpayment remit company amount underpayment result audit performed pursuant this section determined that spepharm over reported information used calculate royalty product result company received more than should have under this agreement spepharm shall entitled credit against royalty company next applicable period amount such excess style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp income each party shall solely responsible payment imposed share income arising directly indirectly from collaborative effort party under this agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp cooperation extent spepharm required deduct withhold payment company spepharm shall amount such proper governmental authority timely manner promptly transmit company official certificate other evidence such withholding sufficient enable company claim such payment company shall provide spepharm form that reasonably necessary order spepharm withhold withhold reduced rate under applicable bilateral income treaty company shall reasonable effort provide such form spepharm least thirty prior date payment which company desire that spepharm apply reduced withholding rate each party shall provide other with reasonable assistance enable recovery permitted applicable withholding value added similar obligation resulting from payment made under this agreement such recovery benefit party bearing such withholding value added style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp resulting from spepharm action spepharm required taxing authority outside united state make payment company subject deduction withholding then such withholding deduction obligation arises result action spepharm including assignment sublicense failure part spepharm comply with applicable filing record retention requirement that effect modifying treatment party hereto ldquo spepharm withholding action rdquo then payable spepharm respect which such deduction withholding required made shall increased extent necessary ensure that company receives equal which would have received such spepharm withholding action occurred otherwise payable spepharm respect which such deduction withholding required made shall made company after deduction amount required deducted withheld which deducted withheld amount shall remitted accordance with applicable provided however that spepharm shall have obligation additional amount extent that deduction withholding would have been imposed failure company qualify exemption from reduction rate withholding under applicable income convention between united state switzerland assignment company right under this agreement redomiciliation company outside united state assertion taxing authority jurisdiction other than united state switzerland that payment spepharm company hereunder derived from source within such other jurisdiction therefore subject withholding such other jurisdiction style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp right spepharm shall have right time retain against amount owing company damage recovered spepharm loss incurred spepharm determined final judgment style font time roman time serif margin text align center text indent nbsp style font time roman time serif margin margin bottom text align center article ndash font style text transform uppercase intellectual property font style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp intellectual property ownership style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp party acknowledge agree that between party except license right granted spepharm hereunder right title interest company patent company know shall reside solely company subject section invention made developed conceived reduced practice behalf spepharm affiliate solely jointly performance this agreement collectively ldquo invention rdquo extent solely related composition matter manufacture development product data other information generated behalf spepharm affiliate solely jointly performance this agreement that solely relate product intellectual property right foregoing including information patent right shall owned company collectively ldquo product rdquo spepharm hereby assigns transfer company right title interest have such product agrees take further reasonably required evidence such assignment transfer company company rsquo cost expense style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp subject section invention that product data other information generated behalf spepharm affiliate solely jointly performance this agreement that solely relate product intellectual property right foregoing including information patent right shall owned spepharm collectively ldquo general rdquo company hereby assigns transfer spepharm right title interest have such general agrees take further reasonably required evidence such assignment transfer spepharm spepharm rsquo cost expense style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp notwithstanding section subject section invention made developed conceived reduced practice jointly spepharm including affiliate company including affiliate performance this agreement data other information jointly generated spepharm including affiliate company including affiliate performance this agreement intellectual property right foregoing including information patent right shall owned jointly spepharm company collectively ldquo joint rdquo each party will have undivided half interest such joint each party will exercise ownership right such joint including right license sublicense otherwise exploit transfer encumber ownership interest without accounting obligation consent required from other party subject license hereunder other term condition this agreement each party hereby assigns other party joint undivided interest joint style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp each party shall promptly disclose other party invention disclosure other similar document submitted employee agent independent contractor describing invention information relating such invention extent necessary preparation filing maintenance patent with respect such invention style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp notwithstanding section subject section each party will solely data generated from clinical study conducted pursuant this agreement that funded solely such party affiliate company will solely data generated from clinical study conducted pursuant this agreement that funded jointly party their respective affiliate ldquo jointly funded data rdquo spepharm hereby assigns transfer company right title interest have such jointly funded data agrees take further reasonably required evidence such assignment transfer company company rsquo cost expense style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp subject term condition this agreement including section spepharm hereby grant company exclusive even spepharm affiliate right license with right grant sublicenses accordance with section mutatis mutandis under general joint extent necessary useful develop market promote import sell offer sale distribute manufacture have manufactured otherwise commercialize product field company territory notwithstanding foregoing spepharm retains right interest general joint ownership right joint other than expressly granted under this section including right practice general joint connection with exercise right granted under section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp patent prosecution maintenance style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp company shall have first right obligation responsible preparation filing prosecution maintenance extension company patent patent right within product licensed territory expense company shall keep spepharm advised status preparation filing prosecution patent application included within company patent licensed territory maintenance extension issued patent within company patent licensed territory shall allow spepharm reasonable opportunity reasonable time review comment regarding relevant material communication draft material response proposed filing company before applicable filing submitted relevant patent office government authority incorporate reasonable comment offered spepharm final filing submitted company relevant patent office government authority licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp company decides file prosecute maintain extend company patent patent right within product each case licensed territory shall give spepharm reasonable notice that effect sufficiently advance deadline filing with respect such patent right permit spepharm carry such activity after such notice spepharm file prosecute maintain extend such patent right perform such reasonably necessary file prosecute maintain extend such patent right sole cost expense provided that spepharm deduct hundred percent cost expense incurred such filing prosecution maintenance extension such patent right from royalty other amount payable spepharm company under this agreement provided that royalty payable company shall reduced more than fifty percent reason this section such payment third party applied reduce royalty result forgoing proviso carried over subsequent calendar quarter applied reduce royalty subject aforementioned fifty percent limitation such subsequent calendar quarter spepharm elect then company shall provide such cooperation spepharm including execution filing appropriate instrument reasonably requested facilitate transition such patent activity style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp filing prosecution maintenance extension patent right within joint will jointly managed party mutually agreeable term including cost expense entered into party time such patent right first filed filing prosecution maintenance extension patent right within general will managed spepharm cost expense style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp party shall cooperate necessary appropriate with each other gaining patent term extension including supplementary protection certificate other extension that become available future wherever applicable patent right that applicable product licensed territory party shall necessary appropriate reasonable effort agree upon joint strategy relating patent term extension absence mutual agreement with respect extension issue patent right shall extended licensed territory only spepharm elect writing extend such patent right style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp trademark license trademark prosecution maintenance enforcement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp product mark subject applicable requirement applicable regulatory authority product shall marketed sold licensed territory using company mark product mark other trade dress logo mutually agreed party accordance with section event that spepharm provides company with written notice indicating good commercial reason removal company mark product mark from product association therewith party shall discus good faith such removal mutually agree upon alternative mark forth section such shall conducted accordance with license right granted hereunder company rsquo trademark usage policy provided from time time writing spepharm available provided that spepharm shall required implement change arising from modified trademark usage policy provided company spepharm would incur additional cost result thereof without spepharm rsquo consent unreasonably withheld other than such change required regulatory authority licensed territory with respect written third party claim that company mark product mark infringes intellectual property right such third party licensed territory spepharm authorized company mark manner except expressly authorized herein spepharm shall acquire right except expressly forth below title interest company mark product mark other trademark trade name service mark owned company spepharm understands agrees that authorized name ldquo navidea rdquo connection with general business imply third party that relationship with company other than licensee under this agreement style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp license usage subject term condition this agreement company hereby grant spepharm affiliate limited exclusive royalty free except provided section right license company rsquo trademark trade name logo that listed part exhibit including replacement successor thereof ldquo company mark rdquo limited exclusive royalty free except provided section right license product mark that listed part exhibit including additional trademark application registration product mark anywhere licensed territory each case solely connection with manufacture sale offer sale keeping whether sale otherwise importation commercialization product hereunder including each case with respect company mark indicate that licensee company product licensed territory only during term this agreement only licensed territory foregoing license shall sublicensable spepharm affiliate sublicensees pursuant accordance with section solely accordance with product provided that right granted spepharm pursuant section shall apply sublicensees spepharm recognizes company rsquo exclusive ownership control company mark product mark agrees comply with reasonable usage requirement quality control guideline with respect company mark product mark company reasonably prescribe writing from time time goodwill resulting from company mark product mark spepharm shall belong inure solely benefit company spepharm shall knowingly undertake that would impair company mark product mark goodwill associated therewith spepharm shall promptly notify company writing actual suspected infringement company mark product mark third party which spepharm becomes aware spepharm shall make permit alteration removal label other identifying mark placed accordance with applicable company product style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp spepharm house mark alternative product mark spepharm rsquo option product packaging marketing material product labeling licensed territory addition company mark product mark carry house mark spepharm affiliate chosen spepharm sole discretion event that product mark available suitable example translation other reason registration particular jurisdiction within licensed territory spepharm shall have right consultation with subject company rsquo written approval unreasonably withheld select alternative trademark with product such jurisdiction addition company mark such alternative trademark shall deemed product mark subject term this section style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp prosecution maintenance style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp company shall have first right obligation responsible clearance preparation filing prosecution maintenance product mark licensed territory expense company shall keep spepharm advised status preparation filing prosecution application product mark licensed territory maintenance registered product mark licensed territory shall allow spepharm reasonable opportunity reasonable time review comment regarding relevant material communication draft material response proposed filing company before applicable filing submitted relevant trademark office government authority incorporate reasonable comment offered spepharm final filing submitted company relevant trademark office government authority licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp company decides clear prepare file prosecute maintain product mark licensed territory shall give spepharm reasonable notice that effect sufficiently advance deadline filing with respect such product mark permit spepharm carry such activity after such notice spepharm clear prepare file prosecute maintain such product mark perform such reasonably necessary clear prepare file prosecute maintain such product mark sole cost expense provided that spepharm deduct hundred percent cost expense incurred such filing prosecution maintenance such product mark from royalty other amount payable spepharm company under this agreement provided that royalty payable company shall reduced more than fifty percent reason this section such payment third party applied reduce royalty result forgoing proviso carried over subsequent calendar quarter applied reduce royalty subject aforementioned fifty percent limitation such subsequent calendar quarter spepharm elect then company shall provide such cooperation spepharm including execution filing appropriate instrument reasonably requested facilitate transition such trademark activity style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp enforcement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp each party will promptly notify writing other party upon learning actual suspected infringement product mark third party claim invalidity unenforceability infringement product mark will along with such notice supply other party with evidence possession pertaining thereto style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp between party spepharm will have first right obligation seek abate infringement product mark licensed territory including file suit against such third party such infringement spepharm take step abate such infringement file suit enforce product mark against such third party within ninety after first notice under section company will have right obligation take action enforce product mark against such third party such infringement controlling party will cost expense incurred such enforcement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp with respect infringement defensive action identified above this section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp controlling party cease pursue withdraws from such action will promptly notify other party good time enable other party meet deadline which action must taken preserve right such infringement defensive action such other party continue substitute itself withdrawing party proceed under term condition this section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp party will reasonably cooperate with each other whether controlling such action including providing access relevant document other evidence making affiliate licensee sublicensees their respective employee subcontractor consultant agent available reasonable business hour reasonable period time only extent relevant such action necessary being joined party subject this clause when joined party controlling such action controlling party agreeing indemnify such controlling party involvement named party such action paying those reasonable cost expense incurred such party connection with such joinder only party controlling such action party controlling such action will keep controlling party updated with respect such action including providing copy document received filed connection with such action style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp only party controlling such action controlling party will have right participate otherwise involved such action each case participating party rsquo sole cost expense party elect participate involved controlling party will provide participating party counsel with opportunity consult with controlling party counsel regarding prosecution such action including reviewing content correspondence legal paper other document related thereto controlling party will take into account reasonable request participating party regarding such enforcement defense style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp neither party will settle consent adverse judgment action described this section including judgment which affect scope validity enforcement product mark involved therewith without prior written consent other party such consent unreasonably withheld delayed style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp unless otherwise agreed party monies recovered upon final judgment settlement action described this section will used first reimburse each party rata basis each their reasonable pocket cost expense relating action with balance such recovery being considered sale style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp patent enforcement defense style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp each party will promptly notify writing other party upon learning actual suspected competitive infringement defined below patent right within company patent product general joint third party claim invalidity unenforceability infringement patent right within company patent product general joint will along with such notice supply other party with evidence possession pertaining thereto purpose this agreement ldquo competitive infringement rdquo mean allegedly infringing activity field licensed territory with respect patent right within company product general joint style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp between party spepharm will have first right obligation seek abate competitive infringement patent right within company patent product general joint licensed territory file suit against such third party such competitive infringement spepharm take step abate such competitive infringement file suit enforce such patent right against such third party with respect such competitive infringement within ninety after first notice under section company will have right obligation take action enforce such patent right against such third party such competitive infringement controlling party will cost expense incurred such enforcement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp between party company will have first right obligation defend against declaratory judgment action other action challenging patent right within company patent product patent right within joint company territory spepharm will have first right obligation defend against declaratory judgment action other action challenging patent right within general patent right within joint licensed territory other than with respect action third party response enforcement action brought pursuant section which defense will controlled party party controlling such enforcement action such party take step defend within commercially reasonably time elect continue such defense which case will promptly provide notice thereof other party then other party will have right obligation defend such patent right style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp with respect infringement defensive action identified above this section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp controlling party cease pursue withdraws from such action will promptly notify other party good time enable other party meet deadline which action must taken preserve right such infringement defensive action such other party continue substitute itself withdrawing party proceed under term condition this section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp party will reasonably cooperate with each other whether controlling such action including providing access relevant document other evidence making affiliate licensee sublicensees their respective employee subcontractor consultant agent available reasonable business hour reasonable period time only extent relevant such action necessary being joined party subject this clause when joined party controlling such action controlling party agreeing indemnify such controlling party involvement named party such action paying those cost expense incurred such party connection with such joinder only party controlling such action party controlling such action will keep controlling party updated with respect such action including providing copy document received filed connection with such action style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp only party controlling such action controlling party will have right participate otherwise involved such action each case participating party rsquo sole cost expense party elect participate involved controlling party will provide participating party counsel with opportunity consult with controlling party counsel regarding prosecution such action including reviewing content correspondence legal paper other document related thereto controlling party will take into account reasonable request participating party regarding such enforcement defense style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp neither party will settle consent adverse judgment action described this section without prior written consent other party such consent unreasonably withheld delayed provided that with respect settlement that limit scope validity enforcement company patent product joint involved therewith company rsquo consent given withheld sole discretion with respect settlement that limit scope validity enforcement general joint involved therewith spepharm rsquo consent given withheld sole discretion style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp unless otherwise agreed party monies recovered upon final judgment settlement action described this section will used first reimburse each party rata basis each their reasonable pocket cost expense relating action with balance such recovery being considered sale style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp third party license company shall have right obtain subject spepharm rsquo prior written approval such approval unreasonably withheld delayed right license third party intellectual property extent company determines that commercially reasonable necessary enable sale product field licensed territory event such approval company spepharm shall share cost payable such third party with respect such license basis event spepharm approve such third party license then company shall free obtain such license sole discretion such intellectual property right shall deemed ldquo controlled rdquo within definition company know company patent style font time roman time serif margin text align center text indent nbsp style font time roman time serif margin margin bottom text align center article ndash font style text transform uppercase representation warranty font style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp representation warranty each party each party hereby represents warrant other party effective date that style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp such party duly organized validly existing good standing under jurisdiction incorporation full corporate power authority enter into this agreement carry provision hereof style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp such party taken necessary action part authorize execution delivery this agreement performance obligation hereunder style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp this agreement been duly executed delivered behalf such party constitutes legal valid binding obligation enforceable against accordance with term hereof style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp execution delivery performance this agreement such party conflict with agreement provision thereof instrument understanding oral written which party which bound violate regulation court governmental body administrative other agency having jurisdiction over such party style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp additional company representation warranty company hereby represents warrant spepharm effective date that style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp true complete copy each upstream agreement each exists effective date including amendment been provided spepharm prior effective date there oral side agreement with respect thereto each upstream agreement full force effect payment date required made thereunder company have been made company compliance material respect with material obligation thereunder company received provided notice termination either upstream agreement notice material breach either upstream agreement company right sublicense right under upstream agreement spepharm within scope license granted section company aware provision under either upstream agreement which could reasonably expected inconsistent with provision this agreement material respect style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp execution delivery performance this agreement company conflict with field license agreement other agreement between company affiliate tcra provision thereof field license agreement only agreement pursuant which company affiliate granted field licensee other person right with respect field style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp exhibit forth complete correct list company patent owned licensed company affiliate company together with affiliate sole exclusive owner licensee sole right title interest company patent listed exhibit owned company company know each case free clear mortgage pledge claim security interest covenant easement encumbrance lien lease sublease option charge kind limitation transfer subordination arrangement favor third party that would preclude grant license right hereunder style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp company patent listed exhibit product mark initial territory force pending have been abandoned effective date company rsquo knowledge such company patent product mark have been duly applied registered accordance with applicable company aware fact circumstance that could reasonably expected impair validity enforceability company patent product mark style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp neither company affiliate granted license option other right kind favor third party under company patent company know product mark licensed territory that inconsistent with this agreement style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp except upstream agreement neither company affiliate party agreement pursuant which company affiliate been licensed granted right company patent company know product mark field licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp there intellectual property right particular patent right owned licensed company affiliate other than company patent company know that necessary spepharm affiliate develop commercialize product forth herein style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp company affiliate have received written oral claim company rsquo knowledge licensor company patent company know received written oral claim ownership inventorship patent infringement trademark infringement other claim intellectual property misappropriation violation from third party including current former officer director employee consultant personnel company predecessor with respect company patent company know product mark product company aware reasonable basis such claim style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp neither company affiliate party otherwise bound oral written contract agreement that shall result person entity obtaining interest that would give entity person right assert claim with respect spepharm rsquo right granted under this agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp there claim judgment settlement pending against company affiliate knowledge company against licensor company patent company know with respect company patent company know product mark product company received notice that such claim judgment settlement threatened style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp except forth schedule company patent subject were developed pursuant funding agreement with government authority style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp knowledge research development manufacture sale offer sale import product form such product exist effective date field licensed territory infringe misappropriate violate intellectual property right third party company affiliate have received written oral claim alleging such infringement misappropriation violation style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp knowledge patent right other intellectual property right owned third party exist that reasonably expected serve basis interference opposition invalidation similar proceeding with respect company patent style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp company furnished made available spepharm material information that company rsquo possession which aware concerning product relevant safety efficacy product regulatory material other correspondence with regulatory authority relating product such information accurate complete true material respect been prepared filed accordance with applicable style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp warranty disclaimer foregoing warranty each party lieu other warranty express implied including implied warranty noninfringement implied warranty merchantability implied warranty fitness particular purpose which hereby specifically excluded disclaimed each party hereby disclaims representation warranty that development manufacture commercialization product under this agreement will successful style font time roman time serif margin text align center text indent nbsp style font time roman time serif margin margin bottom text align center article xiii ndash font style text transform uppercase indemnification font style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp indemnification spepharm spepharm shall indemnify company affiliate their respective officer director employee agent ldquo company indemnitees rdquo reasonable pocket cost expense including court arbitration cost reasonable attorney rsquo appealed appealable judicial arbitration damage award settlement payment collectively ldquo loss rdquo payable owed such party connection with demand investigation lawsuit other legal action third party ldquo third party claim rdquo extent arising from development product undertaken spepharm pursuant spepharm development plan those development plan extended territory contemplated section commercialization product licensed territory including extent caused spepharm rsquo affiliate rsquo sublicensees rsquo label promotion product storage handling transportation product manner that compliant with applicable specification therefrom third party claim based upon product liability breach spepharm rsquo obligation under this agreement including representation warranty covenant agreement part spepharm under this agreement negligence intentional misconduct spepharm affiliate officer director employee agent spepharm affiliate except each case extent caused gross negligence willful misconduct company affiliate their respective officer director employee breach this agreement company foregoing indemnity obligation shall apply extent that third party claim arises from based result from activity forth section which company obligated indemnify spepharm indemnitees style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp indemnification company company shall indemnify spepharm affiliate their respective officer director employee agent ldquo spepharm indemnitees rdquo loss payable owed such party connection with third party claim extent arising from breach company rsquo obligation under this agreement including representation warranty covenant agreement part company under this agreement development product undertaken company pursuant company development plan subject section claim that sale offer sale import product excluding modification product made spepharm product after effective date extent such modification basis such third party claim licensed territory infringes misappropriates violates intellectual property right third party commercialization product company territory including third party claim based upon product liability negligence intentional misconduct company affiliate officer director employee agent company affiliate except each case extent caused gross negligence willful misconduct spepharm affiliate their respective officer director employee breach this agreement spepharm foregoing indemnity obligation shall apply extent that third party claim arises from based result from activity forth section which spepharm obligated indemnify company indemnitees style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp infringement third party claim which indemnity sought spepharm indemnitees pursuant section made appears reasonably possible spepharm agrees promptly notify company writing cooperate with company allow company sole authority control defense settlement such third party claim company rsquo cost expense subject section permit company take such action necessary party rsquo reasonably agree good faith party rsquo equally shared cost expense enable spepharm continue allegedly infringing aspect product obtain license subject section modify replace such infringing material make infringing provided that such modification replacement require spepharm obtain approval from regulatory authority order manufacture sell commercialize product containing such modification replacement event company desire obtain license third party intellectual property right product field territory shall first offer spepharm right obtain such license which case term section shall apply company take such license with prior notice spepharm which term section shall apply event shall company obligated indemnify spepharm third party claim which indemnity sought spepharm indemnitees pursuant section amount excess fifty percent amount paid spepharm company hereunder date such third party claim company cease indemnify spepharm indemnitees such third party claim then spepharm shall have right upon written notice company assume sole authority control defense settlement such third party claim notwithstanding third party claim been filed against spepharm indemnitee court competent jurisdiction which indemnity sought such spepharm indemnitee pursuant section company determines that none foregoing alternative reasonably available provides written notice same spepharm spepharm affiliate sublicensees will have option spepharm rsquo sole discretion either cease sale distribution applicable return such material subject relevant infringement claim continue sale distribution such material which case company rsquo obligation indemnify spepharm indemnitees pursuant section respect such infringement claim shall limited solely liability resulting from sale distribution such material occurring prior receipt such notice from company style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp condition limitation indemnification obligation each party shall notify other event becomes aware claim which indemnification sought hereunder pursuant this section case proceeding including governmental investigation shall instituted involving party respect which indemnity sought pursuant this section such party ldquo indemnified party rdquo shall provide other party ldquo indemnifying party rdquo with prompt written notice such proceeding ldquo indemnification claim notice rdquo promptly after indemnifying party receives indemnification claim notice indemnifying party indemnified party shall meet discus respond claim that subject matter such proceeding option indemnifying party assume defense third party claim subject indemnification provided this section giving written notice indemnified party within thirty within such time provided applicable extension appropriately answer complaint longer than seventy provided that indemnified party make reasonable effort obtain such extension after indemnifying party rsquo receipt indemnification claim notice provided that claim solely seek monetary damage indemnifying party expressly agrees writing that between indemnifying party indemnified party indemnifying party shall solely obligated satisfy discharge claim full matter described ldquo litigation condition rdquo indemnified party time assume such defense litigation condition satisfied upon assuming defense third party claim accordance with this section indemnifying party shall entitled appoint lead counsel defense third party claim should indemnifying party assume continue defense third party claim except otherwise forth this section indemnifying party shall liable indemnified party legal expense subsequently incurred such indemnified party connection with analysis defense settlement third party claim without limiting this section indemnified party shall entitled participate control defense third party claim which sought indemnification hereunder employ counsel choice such purpose provided however that such employment shall indemnified party rsquo expense unless employment thereof been specifically authorized indemnifying party writing indemnifying party failed assume actively further defense employ counsel accordance with this section which case indemnified party shall control defense indemnifying party longer satisfies litigation condition with respect loss relating solely payment money damage connection with third party claim that shall result indemnified party rsquo becoming subject injunctive other relief otherwise adversely affect business indemnified party manner which indemnifying party shall have acknowledged writing obligation indemnify indemnified party hereunder subject litigation condition being satisfied indemnifying party shall have sole right consent entry judgment enter into settlement otherwise dispose such loss such term indemnifying party reasonable discretion shall deem appropriate provided that such term shall include complete unconditional release indemnified party from liability with respect thereto shall transfer indemnified party amount which said indemnified party shall liable prior time entry judgment with respect other loss connection with third party claim where indemnifying party assumed defense third party claim accordance with this article indemnifying party shall have authority consent entry judgment enter into settlement otherwise dispose such liability provided that obtains prior written consent indemnified party which consent shall indemnified party rsquo reasonable discretion indemnifying party that assumed defense third party claim accordance with this article shall liable settlement other disposition loss indemnified party event include court judgment judicial administrative order disposition that reached without written consent such indemnifying party indemnified party shall admit liability with respect settle compromise discharge third party claim without first offering indemnifying party opportunity assume defense third party claim accordance with this article indemnifying party chooses defend prosecute third party claim indemnified party shall cooperate defense prosecution thereof shall furnish such record information testimony provide such witness attend such conference discovery proceeding hearing trial appeal reasonably requested connection with such third party claim such cooperation shall include access during normal business hour afforded indemnifying party reasonable retention indemnified party record information that reasonably relevant such third party claim making employee agent available mutually convenient basis provide additional information explanation material provided hereunder indemnifying party shall reimburse indemnified party reasonable pocket expense incurred connection with such cooperation style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text indent style font time roman time serif margin text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp limitation liability neither party shall liable other special incidental punitive indirect damage loss profit arising from relating breach this agreement regardless notice possibility such damage notwithstanding foregoing nothing this section intended shall limit restrict indemnification right obligation party under section damage available party rsquo infringement misappropriation party rsquo intellectual property right breach confidentiality obligation article section style font time roman time serif margin text align center text indent nbsp style font time roman time serif margin margin bottom text align center article ndash font style text transform uppercase confidentiality font style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp confidentiality exception except extent expressly authorized this agreement otherwise agreed writing party agree that receiving party ldquo receiving party rdquo shall keep confidential shall publish otherwise disclose purpose other than provided this agreement information other confidential proprietary information material patentable otherwise form written oral photographic electronic magnetic otherwise which disclosed other party ldquo disclosing party rdquo otherwise received accessed receiving party course performing obligation exercising right under this agreement including limited trade secret know invention discovery proprietary information formula process technique information relating party rsquo past present future marketing financial research development activity product potential product useful technology disclosing party pricing thereof collectively ldquo confidential information rdquo except extent that established receiving party that such confidential information lawful knowledge possession receiving party prior time disclosed learned receiving party otherwise developed independently receiving party evidenced contemporaneous written record kept ordinary course business other documentary proof actual receiving party generally available public otherwise part public domain time disclosure receiving party hereunder became generally available public otherwise part public domain after disclosure hereunder other than through omission receiving party breach this agreement disclosed receiving party other than under obligation confidentiality third party obligation disclosing party disclose such information others information disclosed under that certain mutual confidentiality disclosure agreement between party dated amended december shall deemed confidential information hereunder such agreement shall superseded term hereof terminated effective effective date style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp authorized disclosure except expressly provided otherwise this agreement receiving party disclose confidential information disclosing party follows receiving party rsquo affiliate potential actual sublicensees subdistributors employee officer director agent consultant other third party under appropriate confidentiality provision stringent than those this agreement connection with performance obligation exercise right under this agreement extent such disclosure reasonably necessary defending litigation complying with applicable governmental regulation otherwise required applicable including required seek obtain maintain product approval provided however that receiving party required applicable make such disclosure disclosing party rsquo confidential information will except where impracticable necessary disclosure example event medical emergency give reasonable advance notice disclosing party such disclosure requirement except extent inappropriate case patent will reasonable effort secure confidential treatment such confidential information required disclosed potential actual acquirer merger candidate investor venture capital firm investment banker other financial institution investor provided that connection with such disclosure such receiving party shall inform each disclosee confidential nature such confidential information cause each disclosee treat such confidential information confidential extent mutually agreed writing party provided however that each above situation receiving party shall remain responsible failure person receives confidential information pursuant this section treat such confidential information required under this article style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp disclosure agreement party have agreed jointly issue public announcement execution this agreement promptly after effective date draft which attached hereto exhibit neither party shall free issue press release other public disclosure regarding agreement other party rsquo activity hereunder except with other party rsquo prior written consent disclosure that reasonably necessary comply with applicable national security exchange listing requirement applicable party agree consult with each other reasonably good faith with respect text timing such press release prior issuance thereof party unreasonably withhold delay condition consent such release except extent required applicable otherwise permitted accordance with this section neither party shall make public announcement concerning this agreement subject matter hereof without prior written consent other which shall unreasonably withheld delayed conditioned notwithstanding foregoing extent information regarding this agreement already been publicly disclosed same context either party subsequently disclose same information public without consent other party each party shall permitted disclose term this agreement each case under appropriate confidentiality provision substantially equivalent those this agreement actual potential investor acquirer merger partner licensee sublicensees purchaser asset such party professional advisor thereof each party shall give other party reasonable opportunity where practical review filing with united state security exchange commission describing term this agreement prior submission such filing shall give consideration reasonable comment filing party relating such filing including without limitation provision this agreement which confidential treatment should sought provided that further review shall provided disclosure which consent been obtained notwithstanding with respect filing this agreement company with united state security exchange commission company shall provide spepharm with least five business review comment such proposed filing style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp publication spepharm recognizes that company wish publish report present scientific information relating product publication report presentation involving product will first submitted company spepharm spepharm will have fifteen review publication report presentation potential patent right other intellectual property right protection spepharm identifies subject matter such publication report presentation which published would adversely affect either party rsquo patent right then upon spepharm rsquo written request company will delay submission publication report presentation additional period exceed ninety order allow filing patent application other appropriate intellectual property protection style font time roman time serif margin text align center text indent nbsp style font time roman time serif margin margin bottom text align center article ndash font style text transform uppercase term termination font style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp term this agreement shall become effective effective date unless earlier terminated pursuant this article shall remain effect product product country country basis until expiration royalty term such country ldquo term rdquo upon expiration this agreement pursuant this section with respect particular product particular country license granted spepharm pursuant section with respect such product such country shall become fully paid terminable with respect particular product particular country spepharm affiliate sublicensees elect continue product mark pursuant section with respect such product such country spepharm shall company royalty equal sale such product such country style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp termination company style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp breach company shall have right terminate this agreement upon thirty rsquo prior written notice spepharm materially breach this agreement cure such breach within ninety thirty payment except otherwise provided this agreement following written notice company which notice shall specify nature breach demand cure provided however that breach spepharm that relates spepharm rsquo obligation under this agreement with respect more specific product more specific country where such breach materially adversely impact performance spepharm obligation under this agreement with respect other product other country shall give company termination right only such affected product country style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp failure launch company shall have right terminate this agreement pursuant section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp termination spepharm breach spepharm shall have right terminate this agreement whole upon thirty rsquo prior written notice company materially breach this agreement cure such breach within ninety following written notice spepharm which notice shall specify nature breach demand cure upon final determination company rsquo material breach under this agreement exhaustion company rsquo cure period lieu termination lieu damage other remedy arising from such breach spepharm shall have right continue with agreement effect including payment obligation assume those activity which company determined material breach activity necessary reasonably required perform such breached activity company affiliate shall reasonably cooperate with spepharm designees facilitate smooth orderly prompt transition spepharm designees such activity style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp tolling notwithstanding section either party alleged material breach dispute good faith such breach termination through dispute resolution procedure forth this agreement then other party rsquo right terminate this agreement shall tolled long such dispute resolution procedure forth article being pursued allegedly breaching party good faith party complying with obligation under this agreement including payment finally conclusively determined that allegedly breaching party material breach then breaching party shall have right cure such material breach after such determination within cure period provided above section applicable style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp insolvency event either company spepharm terminate this agreement other party during term shall file court agency pursuant statute regulation state country petition bankruptcy insolvency reorganization arrangement appointment receiver trustee that party asset other party shall served with involuntary petition against filed insolvency proceeding such petition shall dismissed within sixty after filing thereof other party shall propose party dissolution liquidation other party shall make general assignment benefit creditor termination under this section shall effective upon twenty rsquo prior written notice style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp termination spepharm convenience prior expiration this agreement terminated entirety product product country country basis sole discretion time spepharm effective upon least hundred eighty rsquo prior written notice company reason provided however spepharm terminates this agreement whether whole part major market country such termination shall deemed termination this agreement entirety style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp termination patent challenge company terminate this agreement entirety immediately upon written notice spepharm spepharm affiliate sublicensees directly indirectly individually association with other person entity challenge legal administrative proceeding validity enforceability scope company patent anywhere world except defense against claim action proceeding asserted company affiliate licensee against spepharm affiliate sublicensees ldquo patent challenge rdquo provided that with respect such patent challenge sublicensee spepharm company will have right terminate this agreement under this section spepharm cause such patent challenge terminated dismissed terminates such sublicensee rsquo sublicense company patent being challenged sublicensee each case within thirty company rsquo notice spepharm under this section notwithstanding foregoing company rsquo termination right under this section shall apply affiliate spepharm that first becomes affiliate spepharm after effective date this agreement connection with business combination where such affiliate spepharm undertaking activity connection with patent challenge prior such business combination provided however that spepharm cause such patent challenge terminate within forty five after such business combination avoidance doubt action spepharm accordance with section amend claim within pending patent application company patent during course spepharm rsquo prosecution maintenance such pending patent application defense third party proceeding make negative determination patentability claim patent application company patent abandon patent application company patent during course spepharm rsquo prosecution maintenance such pending patent application shall constitute patent challenge style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp termination pricing reimbursement matter spepharm terminate this agreement thirty rsquo prior written notice market access study contemplated under section generate data adequate spepharm rsquo reasonable judgment support level pricing reimbursement approval initial territory that would make commercially reasonable commercialize product licensed territory achievement pricing reimbursement approval major market country feasible within customary reimbursement timeframes such country reasonably determined spepharm style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp effect termination style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp upon termination this agreement entirety with respect particular product particular country licensed territory then following consequence shall apply style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp each party shall return other party confidential information other party except that each party shall permitted retain through legal counsel copy other party rsquo confidential information extent required under applicable extent necessary exercise right surviving termination this agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp spepharm rsquo right each spepharm company rsquo obligation under this agreement with respect licensed territory such product country applicable shall automatically terminate style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp other committee shall abolished thereafter company shall have right make decision take action previously reserved such other committee style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp trademark mark trade name patent copyright design drawing formula other data photograph sample literature sale promotional every kind including company mark company shall remain sole exclusive property company with respect particular product applicable within thirty after effective date termination this agreement only this agreement terminated entirety spepharm shall destroy tangible item bearing containing contained foregoing possession control provide written certification such destruction prepare such tangible item shipment company company direct company rsquo expense spepharm shall make retain copy confidential proprietary item information which have been entrusted except that spepharm shall permitted retain through legal counsel copy such confidential proprietary item information extent required under applicable extent necessary exercise right surviving termination this agreement effective upon termination this agreement spepharm shall cease company mark with respect particular product country applicable spepharm shall transfer assign company extent already owned company right title interest trademark trade dress logo developed spepharm under this agreement after effective date solely connection with commercializing product licensed territory intellectual property right marketing material style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp spepharm hereby grant company worldwide fully paid royalty free right license with right grant sublicenses through multiple tier subject subsection xiii below under general that prior termination been developed company assigned spepharm which necessary reasonably useful develop market promote import sell offer sale distribute manufacture have manufactured otherwise commercialize product solely develop market promote import sell offer sale distribute manufacture have manufactured otherwise commercialize product other product foregoing license shall exclusive with respect product exclusive with respect other product style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp requested company spepharm shall grant company exclusive even spepharm affiliate worldwide royalty bearing right license with right grant sublicenses through multiple tier subject subsection xiii below under general extent licensed under section above joint spepharm which necessary reasonably useful develop market promote import sell offer sale distribute manufacture have manufactured otherwise commercialize product solely develop market promote import sell offer sale distribute manufacture have manufactured otherwise commercialize product party shall establish commercially reasonable royalty rate term such license prior effective date termination event party unable agree then matter shall decided independent industry expert selected company reasonably acceptable spepharm until such matter finally resolved spepharm will grant license royalty free basis with finally determined royalty applying retroactive basis date first sale product company under license granted hereunder addition company would responsible rata share cost expense owed spepharm third party pursuant license under which spepharm procured third party technology constituting spepharm hereunder style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp neither party shall released from paying amount which accrued prior effective date such termination style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent viii nbsp nbsp nbsp nbsp nbsp nbsp company reasonable discretion accordance with applicable appoint itself successor spepharm appoint third party that located licensed territory organized under licensed territory legally competent hold maintain product approval with respect particular product applicable under licensed territory successor spepharm solely those product country that have been terminated ldquo successor entity rdquo spepharm shall transfer assign company successor entity applicable permit filing authorization product approval including reimbursement authorization obtained maintained renewed that under spepharm rsquo name that held spepharm solely purpose marketing distributing selling terminated product terminated country licensed territory soon practicable after this agreement terminated company rsquo expense spepharm shall reasonably cooperate company rsquo request expense making filing executing instrument taking other action reasonably necessary make such transfer product approval including pricing approval effective addition spepharm shall transfer assign company regulatory material licensed territory that controlled spepharm style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp spepharm shall company rsquo request expense promptly assign company successor entity applicable spepharm rsquo right obligation under contract extent assignable such terminated product terminated country territory with third party extent solely related development commercialization product licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp spepharm shall provide company with complete inventory product spepharm rsquo possession transit spepharm from company otherwise spepharm rsquo control within after effective date termination company inspect spepharm rsquo product inventory audit spepharm rsquo record manner provided hereinabove acceptance product order from sale license product spepharm after effective date termination this agreement shall construed renewal extension hereof waiver termination this agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp company shall option have right repurchase from spepharm spepharm shall sell company product country which this agreement terminated applicable spepharm rsquo stock applicable repurchase price actually paid spepharm such product such repurchase shall made within sixty after effective date termination spepharm shall promptly ship such product destination specified company accordance with shipping instruction used company spepharm such product part delivered shall subject inspection company completed later than business after receipt payment therefore shall made within forty five final acceptance company such product inspected company shall purchase from spepharm spepharm agrees sell company spepharm rsquo inventory terminated product applicable that obsolete damaged expired effective date such termination price such inventory shall spepharm rsquo fully burdened cost good ldquo repurchase price rdquo product repurchased from spepharm company pursuant this section shall shipped promptly spepharm location specified company company shall reimburse spepharm approved reasonable pocket cost shipment style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp period exceed following effective date termination this agreement spepharm affiliate shall reasonably cooperate with company designees facilitate smooth orderly prompt transition company designees activity with respect product including ongoing development manufacturing commercialization product including agreement related product which spepharm unable assign company elect assign company such agreement being solely related product during pendency transition spepharm will take action that would reasonably expected have material adverse effect product connection with transfer activity under this section party will develop agree upon written plan effect such transition company shall reimburse spepharm reasonable cost expense incurred with such transfer style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent xiii nbsp nbsp nbsp nbsp nbsp nbsp nbsp with respect each sublicense granted company pursuant subsection above company shall remain primarily responsible affiliate rsquo sublicensees rsquo activity failure affiliate sublicensees comply with applicable term this agreement party agree that agreement with third party acting only distributor wholesaler company affiliate providing product service company affiliate which otherwise granted sublicense spepharm rsquo right under this agreement shall deemed sublicense within fifteen after entering into sublicense agreement general spepharm product with affiliated sublicensee company shall provide spepharm copy executed sublicense agreement which redacted necessary protect commercially sensitive information style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp survival termination expiration this agreement reason shall without prejudice right that shall have accrued benefit party prior such termination relinquishment expiration including payment obligation hereunder damage remedy arising from breach hereunder such termination relinquishment expiration shall relieve party from obligation which expressly indicated survive termination this agreement provision article xiii xvii section amount accrued prior effective date termination long norgine elect license under section shall survive expiration termination this agreement reason other right obligation party shall cease upon termination this agreement style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin margin bottom text align center article ndash dispute style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp dispute party shall attempt resolve dispute between party arising relating this agreement related agreement collectively separately amicably through good faith discussion upon written request party event dispute arising relating this agreement either party shall provide written notice dispute other which event dispute shall referred executive officer designated below their successor attempted resolution good faith negotiation within thirty after such notice received said designated officer initially follows style font time roman time serif margin nbsp table cellspacing cellpadding align center style font time roman time serif width border collapse collapse style vertical align nowrap style width company nowrap style width nbsp president style vertical align nowrap nbsp nowrap nbsp style vertical align nowrap spepharm nowrap nbsp nbsp managing director table style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent event designated executive officer resolve such dispute within allotted sixty such dispute resolved litigation pursuant section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp venue jurisdiction each party hereby irrevocably unconditionally consent submit exclusive jurisdiction federal court located southern district york action suit proceeding arising relating this agreement transaction contemplated hereby each party hereby irrevocably unconditionally waif objection laying venue action suit proceeding arising relating this agreement transaction contemplated hereby federal court located southern district york waif agrees plead claim such court that such action suit proceeding brought such court been brought inconvenient forum notwithstanding foregoing party shall entitled seek enforcement judgment entered pursuant this section court having competent jurisdiction thereof where enforcement deemed necessary style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp exclusion nothing this article shall preclude party from seeking obtaining court competent jurisdiction injunctive equitable relief preserve status prevent immediate harm party term this article shall apply dispute relating material breach article confidentiality claim relating intellectual property right party each which brought court competent jurisdiction style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin margin bottom text align center article xvii ndash font style text transform uppercase miscellaneous font style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp force majeure nonperformance either party shall excused extent that performance rendered beyond such party rsquo reasonable control industrial conflict mobilization requisition embargo currency restriction insurrection general shortage transport material power supply fire flood earthquake explosion stroke lightning other force majeure similar casualty other event beyond either party rsquo reasonable control ldquo force majeure event rdquo well default delivery from subcontractor such circumstance defined this section force majeure event exists more than hundred eighty then affected party shall have right terminate this agreement upon written notice other party term section shall apply either party affected force majeure event shall promptly soon known that such circumstance likely have detrimental impact performance obligation under term this agreement immediately verbally notify other party follow writing describing nature extent circumstance likely potential duration foreseeable impact ability perform obligation under this agreement during continuance force majeure event affected party shall reasonable effort overcome remove minimize effect such force majeure event perform obligation under this agreement soon reasonably possible style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp performance affiliate each party agrees cause affiliate comply with provision this agreement applicable such affiliate guarantee payment performance thereof breach party rsquo affiliate such party rsquo obligation under this agreement will deemed breach such party other party proceed directly against such party without obligation first proceed against such party rsquo affiliate style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp independent contractor understood that both party independent contractor engaged operation their respective business neither party agent other purpose whatsoever neither party authority express implied enter into contract assume obligation other pledge credit other make warranty representation behalf other except where expressly authorized writing nothing this agreement activity either party shall deemed create agency partnership joint venture relationship style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp partnership party agree acknowledge that this agreement intended create deemed otherwise treated partnership united state federal state local income purpose purpose state united state district columbia party shall file cause filed internal revenue service form return partnership income equivalent form state local purpose with respect arrangement contemplated this agreement each party agrees that united state federal state local income return file will consistent with provision this section transaction contemplated this agreement shall conducted under joint combined business name party shall hold itself person being partnership joint venture combined business with other party party shall open joint bank account otherwise commingle their respective fund style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp notice notice request claim demand other communication hereunder shall writing shall given shall deemed have been duly given upon receipt delivery person internationally recognized overnight delivery registered certified mail postage prepaid return receipt requested facsimile email with confirming letter sent mail provided above following address such other address which such party give notice hereunder style font time roman time serif margin text indent nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse margin left style vertical align style width spepharm style width spepharm style vertical align nbsp kapellplatz style vertical align nbsp nbsp nbsp style vertical align nbsp luzern switzerland style vertical align nbsp attention nbsp nbsp adrian segesser style vertical align nbsp nbsp nbsp style vertical align nbsp nbsp style vertical align with copy norgine nbsp style vertical align nbsp nbsp style vertical align norgine norgine style vertical align nbsp hogehilweg style vertical align nbsp amsterdam zuid oost style vertical align nbsp netherlands style vertical align nbsp attention managing director style vertical align nbsp style vertical align nbsp nbsp style vertical align company navidea biopharmaceuticals style vertical align nbsp blazer parkway suite style vertical align nbsp dublin style vertical align nbsp attention president style vertical align nbsp nbsp table style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse margin left style vertical align colspan style text align justify with copy which shall constitute notice style vertical align style width text align justify nbsp style width text align justify nbsp style vertical align nbsp cooley style vertical align nbsp freedom square style vertical align nbsp reston town center style vertical align nbsp freedom drive style vertical align nbsp reston nbsp nbsp style vertical align nbsp united state america style vertical align nbsp attention nbsp nbsp krisko table style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify notice shall considered delivered when mailed sent confirmed email facsimile accordance with provision this section subject proof receipt facsimile confirmation mail receipt style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp governing this agreement right obligation party hereunder shall governed construed interpreted accordance with state york without reference conflict choice principle excluding united nation convention contract international sale good style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp entire agreement this agreement including exhibit forth entire agreement understanding party relating subject matter hereof supersedes prior oral written contemporaneous oral agreement understanding arrangement modification amendment this agreement shall effective unless signed party style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp assignment this agreement assigned either party either party delegate obligation otherwise transfer license other right created this agreement except expressly permitted hereunder otherwise without prior written consent other party which consent will unreasonably withheld delayed conditioned provided that without consent spepharm assign this agreement affiliate norgine long norgine affiliate spepharm successor connection with merger consolidation sale substantially asset that portion business pertaining subject matter this agreement company assign this agreement affiliate successor connection with merger consolidation sale substantially asset that portion business pertaining subject matter this agreement provided however that except case where party involved merger consolidation where surviving entity asset such party have been transferred result such merger consolidation that such assigning party provides other party this agreement with least thirty advance written notice such assignment subject confidentiality obligation assigning party agrees written agreement delivered prior such assignment assigning party upon which such assigning party rely remain fully liable performance obligation under this agreement assignee assignee agree written agreement delivered prior such assignment assigning party upon which such assigning party rely assume performance such assigned obligation case assignment company right company patent company know licensed spepharm licensed territory will transferred such assignee effective such assignment matter referred clause applicable will forth documentation reasonably acceptable assigning party prior such assignment with such reasonable acceptance unreasonably withheld conditioned delayed case will provide assigning party with full benefit right under this agreement after taking into account risk involving applicable counter party performance bankruptcy insolvency risk including those involving contractual rejection under sect such assignment occurred term this agreement will binding upon will inure benefit successor heir administrator permitted assigns party purported assignment violation this section will null void initio style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp nbsp nbsp guaranty consideration right granted hereunder norgine hereby guarantee favor company full payment performance spepharm obligation spepharm under this agreement accordance with term condition this agreement including applicable notice cure period this guaranty shall enforceable upon failure spepharm perform obligation have under this agreement accordance with term shall effective regardless solvency insolvency spepharm time extension modification obligation this agreement operation subsequent reorganization merger consolidation other restructuring spepharm norgine hereby expressly waif requirement that company exhaust right power remedy under this agreement proceed against other spepharm entity under this agreement obligation performance hereunder prior proceeding directly against norgine under this section event that this agreement transferred assigned spepharm third party which affiliate norgine business combination occurs with respect spepharm third party which affiliate norgine then norgine rsquo obligation under this section shall terminate successor spepharm rsquo right this agreement successor spepharm case maybe shall assume such obligation under this section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp severability provision this agreement held invalid court competent jurisdiction then remaining provision shall remain nevertheless full force effect party agree renegotiate good faith term held invalid bound agreed substitute provision order give most approximate effect intended party style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp heading heading contained this agreement reference purpose only shall affect meaning interpretation this agreement article section recital exhibit schedule party reference this agreement unless otherwise stated party counsel shall deemed drafter this agreement purpose construing provision hereof provision this agreement shall construed accordance with their fair meaning strictly against party style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp export control spepharm understands acknowledges that company subject regulation agency government including limited department commerce which prohibit regulate export diversion certain product technology certain country obligation company provide product well other technical information assistance shall subject respect such united state regulation shall from time time govern license delivery technology product abroad person subject jurisdiction united state including without limitation administration amended successor legislation export administration regulation issued department commerce bureau import administration spepharm agrees cooperate with company including without limitation providing required documentation order obtain export license exemption there from company warrant that shall comply with export administration regulation other united state regulation governing export effect from time time company further warrant that effective date nothing export administration regulation other united state regulation governing export restrict company from providing product technical information assistance relating thereto spepharm required this agreement from performing company rsquo obligation under this agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp waiver waiver term condition this agreement shall valid binding either party unless agreed writing party charged failure either party enforce time provision agreement failure require time performance other party provision this agreement shall construed present future waiver such provision affect validity either party enforce each every such provision thereafter style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent nbsp nbsp nbsp nbsp nbsp counterpart this agreement executed counterpart each which shall deemed original both which together shall constitute same instrument each party execute this agreement facsimile transmission adobe trade portable document format ldquo rdquo sent electronic mail addition facsimile signature authorized signatory party will deemed original signature will valid binding delivery facsimile signature party will constitute execution delivery this agreement style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent witness whereof intending legally bound hereby party have caused this agreement executed their duly authorized representative effective date style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify navidea biopharmaceuticals style font time roman time serif margin text align justify nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width text align justify style width border bottom black solid text align justify nbsp style vertical align style text align justify nbsp style text align justify nbsp style vertical align colspan style text align justify name style vertical align colspan style text align justify nbsp style vertical align colspan style text align justify title table style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify spepharm style font time roman time serif margin text align justify nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width text align justify style width border bottom black solid text align justify nbsp style vertical align style text align justify nbsp style text align justify nbsp style vertical align colspan style text align justify name style vertical align colspan style text align justify nbsp style vertical align colspan style text align justify title table style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify norgine solely purpose section article style font time roman time serif margin text align justify nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width text align justify style width border bottom black solid text align justify nbsp style vertical align style text align justify nbsp style text align justify nbsp style vertical align colspan style text align justify name style vertical align colspan style text align justify nbsp style vertical align colspan style text align justify title table style font time roman time serif margin text align center nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width field sequence type arabic name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center exhibit style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center company patent style font time roman time serif margin nbsp style font time roman time serif margin patent style font time roman time serif margin nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width border black solid padding right padding left style font time roman time serif margin nbsp style font time roman time serif margin ldquo composition radiolabeling dtpa dextran rdquo style font time roman time serif margin lymphoseek formulation style font time roman time serif margin style font time roman time serif margin style width border black solid border right black solid border bottom black solid padding right padding left font style font size assigned navidea font style width border black solid border right black solid border bottom black solid padding right padding left font style font size issued ndash font style vertical align style border right black solid border bottom black solid border left black solid padding right padding left style font time roman time serif margin nbsp style font time roman time serif margin ldquo macromolecular carrier drug diagnostic agent delivery rdquo style font time roman time serif margin lymphoseek composition style font time roman time serif margin style font time roman time serif margin style font time roman time serif margin nbsp style border right black solid border bottom black solid padding right padding left font style font size licensed from ucsd font style border right black solid border bottom black solid padding right padding left font style font size expiration font table style font time roman time serif margin nbsp field page sequence option newsection value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width exhibit field sequence type lowerroman name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin text align center nbsp nbsp style font time roman time serif margin text align center exhibit style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center press release style font time roman time serif margin nbsp style font time roman time serif margin text align center font style font size navidea norgine enter european commercial partnership lymphoseek navidea receive million upfront payment font style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center strategic partnership provides market development sale marketing infrastructure lymphoseek expansion into european marketplace ndash style font time roman time serif margin nbsp style font time roman time serif margin text align justify dublin ohio march mdash navidea biopharmaceuticals nyse navb spepharma affiliate norgine european specialist pharmaceutical company with extensive european presence today entered into exclusive sublicense agreement commercialization distribution lymphoseek microgram radiopharmaceutical preparation tilmanocept european union under term agreement navidea will receive upfront payment million eligible receive additional milestone payment million well royalty european sale style font time roman time serif margin nbsp style font time roman time serif margin text align justify background color white lymphoseek receptor targeted radiopharmaceutical imaging agent approved food drug administration november lymphoseek approved europe imaging intraoperative detection sentinel lymph node patient with breast cancer melanoma localized squamous cell carcinoma oral cavity these font style background color white procedure lymph node adjacent primary tumor that contain tumor metastasis identified biopsied determine cancer spread these lymph node font style font time roman time serif margin text align justify background color white nbsp style font time roman time serif margin text align justify ldquo launching lymphoseek global market integral navidea rsquo corporate growth strategy believe that norgine rsquo commercial medical development expertise combined with well established infrastructure strong presence european marketplace make ideal commercialization partner gain country country reimbursement drive lymphoseek adoption rdquo said rick gonzalez president chief executive officer navidea ldquo anticipate successful mutually beneficial partnership with norgine based synergistic core competency shared vision value creation strong commitment providing highly differentiated product that improve diagnosis treatment disease patient with unmet medical need rdquo style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify ldquo this agreement with navidea underscore norgine rsquo vision partner choice facilitates growth expansion specialist product portfolio help improve treatment patient throughout europe rdquo said peter stein chief executive officer norgine ldquo look forward fully engaging sale force support commercial launch activity marketplace requiring alternative rdquo style font time roman time serif margin nbsp style font time roman time serif margin text align justify ldquo securing partner with commitment market access development especially important since unlike united state where institution typically rely unit dose distribution radiopharmaceutical product specialized radio pharmacy distributor institution europe purchase radiolabeled material compound finished product site rdquo added gonzalez ldquo specialist pharmaceutical company norgine optimally positioned interface directly with targeted surgical oncologist customer base with dedicated sale force expect norgine begin market access work immediately major market europe with goal supporting commercial launch sometime early rdquo style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width exhibit field sequence type lowerroman name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify under term exclusive license agreement navidea will supply packaged lymphoseek product norgine however navidea will transfer responsibility regulatory maintenance lymphoseek marketing authorization norgine norgine will also responsible pricing reimbursement sale marketing medical affair regulatory connection with entering into agreement navidea will entitled upfront payment million milestone totaling additional million well royalty european sale initial territory covered agreement includes member state european economic community with option expand into additional geographical area additional term agreement were disclosed style font time roman time serif margin nbsp style font time roman time serif margin text align justify background color white about lymphoseek style font time roman time serif margin text align justify background color white font style font family time roman time serif lymphoseek font font style font family time roman time serif technetium tilmanocept injection first only approved receptor targeted lymphatic mapping agent novel receptor targeted small molecule radiopharmaceutical used evaluation lymphatic basin that have cancer involvement patient lymphoseek designed precise identification lymph node that drain from primary tumor which have highest probability harboring cancer lymphoseek approved food drug administration solid tumor cancer where lymphatic mapping component surgical management guiding sentinel lymph node biopsy patient with clinically node negative breast cancer melanoma squamous cell carcinoma oral cavity lymphoseek also received european approval imaging intraoperative detection sentinel lymph node patient with melanoma breast cancer localized squamous cell carcinoma oral cavity font style font time roman time serif margin text align justify background color white nbsp style font time roman time serif margin text align justify background color white accurate diagnostic evaluation cancer critical guide therapy decision determines patient prognosis risk recurrence overall solid tumor cancer represent million case year sentinel node label europe address approximately case breast cancer case melanoma case head neck oral cancer approximately case breast cancer case melanoma case head neck oral cancer diagnosed europe annually style font time roman time serif margin text align justify background color white nbsp style font time roman time serif margin lymphoseek microgram radiopharmaceutical preparation tilmanocept style font time roman time serif margin text align justify background color white indication important safety information style font time roman time serif margin text align justify background color white radiolabelled lymphoseek indicated imaging intraoperative detection sentinel lymph node draining primary tumour adult patient with breast cancer melanoma localised squamous cell carcinoma oral cavity style font time roman time serif margin text align justify background color white nbsp style font time roman time serif margin text align justify background color white external imaging intraoperative evaluation performed using gamma detection device style font time roman time serif margin text align justify background color white nbsp style font time roman time serif margin text align justify background color white important safety information about lymphoseek patient style font time roman time serif margin text align justify background color white clinical trial with lymphoseek serious hypersensitivity reaction were reported however lymphoseek pose risk such reaction chemical similarity dextran serious hypersensitivity reaction have been associated with dextran modified form dextran such iron dextran drug style font time roman time serif margin text align justify background color white nbsp style font time roman time serif margin text align justify background color white prior administration lymphoseek patient should asked about previous hypersensitivity reaction drug particular dextran modified form dextran resuscitation equipment trained personnel should available time lymphoseek administration patient observed sign symptom hypersensitivity following injection style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width exhibit field sequence type lowerroman name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text align justify background color white nbsp style font time roman time serif margin text align justify background color white radiation emitting product increase risk cancer adhere dose recommendation ensure safe handling minimize risk excessive radiation exposure patient health care worker style font time roman time serif margin text align justify background color white clinical trial patient experienced serious adverse reaction most common adverse reaction were injection site irritation pain style font time roman time serif margin text align justify background color white nbsp style font time roman time serif margin text align justify background color white prescribing information more information about lymphoseek patient will available http europa health document community register html style font time roman time serif margin text align justify background color white nbsp style font time roman time serif margin text align justify background color white full prescribing information more information about lymphoseek patient please visit lymphoseek style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify about norgine style font time roman time serif margin text align justify norgine european specialist pharmaceutical company that been established over year norgine provides expertise lsquo know rsquo europe develop manufacture market product that offer real value healthcare professional payer patient norgine rsquo approach infrastructure integrated focused upon ensuring that norgine partnership opportunity growth norgine headquartered netherlands global operation based amsterdam harefield norgine owns site hengoed wale manufacturing site hengoed wale dreux france more information please visit norgine norgine established complementary business norgine venture supporting innovative healthcare company through provision debt like financing europe more information please visit norgineventures style font time roman time serif margin nbsp style font time roman time serif margin text align justify about navidea biopharmaceuticals style font time roman time serif margin text align justify background color white font style font family time roman time serif navidea biopharmaceuticals nyse navb commercial stage precision medicine company focused development commercialization precision diagnostics therapeutic radiopharmaceutical agent navidea developing multiple precision targeted product platform including manocept trade help identify site pathway undetected disease enable better diagnostic accuracy clinical decision making targeted treatment ultimately patient care lymphoseek font font style font family time roman time serif font font style font family time roman time serif technetium tilmanocept injection navidea rsquo first commercial product from manocept platform approved march november navidea rsquo strategy deliver superior growth shareholder return bringing market novel radiopharmaceutical agent therapeutic advancing company rsquo pipeline through global partnering commercialization effort more information please visit navidea font style font time roman time serif margin nbsp style font time roman time serif margin text align justify private security litigation reform provides safe harbor forward looking statement made behalf company statement this news release which relate other than strictly historical fact such statement about company rsquo plan strategy expectation future financial performance existing product technology anticipated clinical regulatory pathway market company rsquo product forward looking statement within meaning word ldquo believe rdquo ldquo expect rdquo ldquo anticipate rdquo ldquo estimate rdquo ldquo project rdquo similar expression identify forward looking statement that speak only date hereof investor cautioned that such statement involve risk uncertainty that could cause actual result differ materially from historical anticipated result many factor including limited company rsquo continuing operating loss uncertainty market acceptance product reliance third party manufacturer accumulated deficit future capital need uncertainty capital funding dependence limited product line distribution channel competition limited marketing manufacturing experience risk development product regulatory risk other risk detailed company rsquo most recent annual report form other security exchange commission filing company undertakes obligation publicly update revise forward looking statement style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width exhibit field sequence type lowerroman name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp style font time roman time serif margin color style font time roman time serif margin contact style font time roman time serif margin text align justify nbsp style font time roman time serif margin source navidea biopharmaceuticals style font time roman time serif margin navidea biopharmaceuticals style font time roman time serif margin nbsp style font time roman time serif margin brent larson style font time roman time serif margin executive style font time roman time serif margin style font time roman time serif margin sharon correia style font time roman time serif margin associate director corporate communication style font time roman time serif margin text align center style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width exhibit field sequence type lowerroman name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp style font time roman time serif margin text align center exhibit style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center company mark product mark style font time roman time serif margin nbsp style font time roman time serif margin part ndash company mark style font time roman time serif margin nbsp style font time roman time serif margin navidea style font time roman time serif margin nbsp style font time roman time serif margin tlogo style font time roman time serif margin nbsp table cellspacing cellpadding style width font time roman time serif border collapse collapse margin bottom style vertical align style width border black solid padding right padding left style font time roman time serif margin ldquo navidea rdquo style font time roman time serif margin trademark style font time roman time serif margin trademark style font time roman time serif margin canada application style font time roman time serif margin japan application style font time roman time serif margin china application style font time roman time serif margin nbsp style width border black solid border right black solid border bottom black solid padding right padding left style font time roman time serif margin nbsp style font time roman time serif margin renewal style font time roman time serif margin nbsp style font time roman time serif margin renewal style vertical align style border right black solid border bottom black solid border left black solid padding right padding left style font time roman time serif margin ldquo navidea biopharmaceuticals rdquo style font time roman time serif margin design word style font time roman time serif margin trademark style font time roman time serif margin nbsp style border right black solid border bottom black solid padding right padding left font style font size renewal font table style font time roman time serif margin nbsp style font time roman time serif margin part ndash product mark style font time roman time serif margin nbsp style font time roman time serif margin lymphoseek style font time roman time serif margin nbsp style font time roman time serif margin tlogo style font time roman time serif margin nbsp table cellspacing cellpadding style width font time roman time serif border collapse collapse margin bottom style vertical align style width border black solid padding right padding left style font time roman time serif margin ldquo lymphoseek rdquo style font time roman time serif margin trademark style font time roman time serif margin trademark style font time roman time serif margin canada application style font time roman time serif margin japan application style font time roman time serif margin china application style font time roman time serif margin nbsp style width border black solid border right black solid border bottom black solid padding right padding left style font time roman time serif margin nbsp style font time roman time serif margin renewal style font time roman time serif margin nbsp style font time roman time serif margin renewal style vertical align style border right black solid border bottom black solid border left black solid padding right padding left style font time roman time serif margin ldquo lymphoseek technetium tilmanocept injection rdquo style font time roman time serif margin design word style font time roman time serif margin trademark application style font time roman time serif margin nbsp style border right black solid border bottom black solid padding right padding left font style font size pending font table style font time roman time serif margin text align center nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width exhibit field sequence type lowerroman name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin text align center nbsp nbsp style font time roman time serif margin text align center exhibit style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center pharmacovigilance agreement style font time roman time serif margin nbsp style font time roman time serif margin attached within style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width exhibit field sequence type lowerroman name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center exhibit style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center expanded territory style font time roman time serif margin text align center nbsp style font time roman time serif margin style font time roman time serif margin nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width exhibit field sequence type lowerroman name pageno viii field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align center exhibit style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center summary supply agreement term style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width exhibit field sequence type lowerroman name pageno field sequence table style page break before always margin margin bottom table cellpadding cellspacing style width font time roman time serif style text align center width nbsp table field page style font time roman time serif margin nbsp style font time roman time serif margin text align center exhibit style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center company development plan style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center supplied style font time roman time serif margin text align center nbsp field page sequence option last style margin margin bottom border bottom black solid table cellpadding cellspacing style width font time roman time serif style text align center width exhibit field sequence type lowerroman name pageno field sequence table field page style font time roman time serif margin nbsp style font time roman time serif margin nbsp style margin body html text document